Adiposity and cancer survival: a systematic review and meta-analysis
Purpose The increasing availability of clinical imaging tests (especially CT and MRI) that directly quantify adipose tissue has led to a rapid increase in studies examining the relationship of visceral, subcutaneous, and overall adiposity to cancer survival. To summarize this emerging body of litera...
Saved in:
Published in | Cancer causes & control Vol. 33; no. 10; pp. 1219 - 1246 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.10.2022
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose
The increasing availability of clinical imaging tests (especially CT and MRI) that directly quantify adipose tissue has led to a rapid increase in studies examining the relationship of visceral, subcutaneous, and overall adiposity to cancer survival. To summarize this emerging body of literature, we conducted a systematic review and meta-analysis of imaging-measured as well as anthropometric proxies for adipose tissue distribution and cancer survival across a wide range of cancer types.
Methods
Using keywords related to adiposity, cancer, and survival, we conducted a systematic search of the literature in PubMed and MEDLINE, Embase, and Web of Science Core Collection databases from database inception to 30 June 2021. We used a random-effect method to calculate pooled hazard ratios (HR) and corresponding 95% confidence intervals (CI) within each cancer type and tested for heterogeneity using Cochran’s
Q
test and the
I
2
test.
Results
We included 203 records for this review, of which 128 records were utilized for quantitative analysis among 10 cancer types: breast, colorectal, gastroesophageal, head and neck, hepatocellular carcinoma, lung, ovarian, pancreatic, prostate, and renal cancer. We found that imaging-measured visceral, subcutaneous, and total adiposity were not significantly associated with increased risk of overall mortality, death from primary cancer, or cancer progression among patients diagnosed with these 10 cancer types; however, we found significant or high heterogeneity for many cancer types. For example, heterogeneity was similarly high when the pooled HRs (95% CI) for overall mortality associated with visceral adiposity were essentially null as in 1.03 (0.55, 1.92;
I
2
= 58%) for breast, 0.99 (0.81, 1.21;
I
2
= 71%) for colorectal, versus when they demonstrated a potential increased risk 1.17 (0.85, 1.60;
I
2
= 78%) for hepatocellular carcinoma and 1.62 (0.90, 2.95;
I
2
= 84%) for renal cancer.
Conclusion
Greater adiposity at diagnosis (directly measured by imaging) is not associated with worse survival among cancer survivors. However, heterogeneity and other potential limitations were noted across studies, suggesting differences in study design and adiposity measurement approaches, making interpretation of meta-analyses challenging. Future work to standardize imaging measurements and data analyses will strengthen research on the role of adiposity in cancer survival. |
---|---|
AbstractList | The increasing availability of clinical imaging tests (especially CT and MRI) that directly quantify adipose tissue has led to a rapid increase in studies examining the relationship of visceral, subcutaneous, and overall adiposity to cancer survival. To summarize this emerging body of literature, we conducted a systematic review and meta-analysis of imaging-measured as well as anthropometric proxies for adipose tissue distribution and cancer survival across a wide range of cancer types.PURPOSEThe increasing availability of clinical imaging tests (especially CT and MRI) that directly quantify adipose tissue has led to a rapid increase in studies examining the relationship of visceral, subcutaneous, and overall adiposity to cancer survival. To summarize this emerging body of literature, we conducted a systematic review and meta-analysis of imaging-measured as well as anthropometric proxies for adipose tissue distribution and cancer survival across a wide range of cancer types.Using keywords related to adiposity, cancer, and survival, we conducted a systematic search of the literature in PubMed and MEDLINE, Embase, and Web of Science Core Collection databases from database inception to 30 June 2021. We used a random-effect method to calculate pooled hazard ratios (HR) and corresponding 95% confidence intervals (CI) within each cancer type and tested for heterogeneity using Cochran's Q test and the I2 test.METHODSUsing keywords related to adiposity, cancer, and survival, we conducted a systematic search of the literature in PubMed and MEDLINE, Embase, and Web of Science Core Collection databases from database inception to 30 June 2021. We used a random-effect method to calculate pooled hazard ratios (HR) and corresponding 95% confidence intervals (CI) within each cancer type and tested for heterogeneity using Cochran's Q test and the I2 test.We included 203 records for this review, of which 128 records were utilized for quantitative analysis among 10 cancer types: breast, colorectal, gastroesophageal, head and neck, hepatocellular carcinoma, lung, ovarian, pancreatic, prostate, and renal cancer. We found that imaging-measured visceral, subcutaneous, and total adiposity were not significantly associated with increased risk of overall mortality, death from primary cancer, or cancer progression among patients diagnosed with these 10 cancer types; however, we found significant or high heterogeneity for many cancer types. For example, heterogeneity was similarly high when the pooled HRs (95% CI) for overall mortality associated with visceral adiposity were essentially null as in 1.03 (0.55, 1.92; I2 = 58%) for breast, 0.99 (0.81, 1.21; I2 = 71%) for colorectal, versus when they demonstrated a potential increased risk 1.17 (0.85, 1.60; I2 = 78%) for hepatocellular carcinoma and 1.62 (0.90, 2.95; I2 = 84%) for renal cancer.RESULTSWe included 203 records for this review, of which 128 records were utilized for quantitative analysis among 10 cancer types: breast, colorectal, gastroesophageal, head and neck, hepatocellular carcinoma, lung, ovarian, pancreatic, prostate, and renal cancer. We found that imaging-measured visceral, subcutaneous, and total adiposity were not significantly associated with increased risk of overall mortality, death from primary cancer, or cancer progression among patients diagnosed with these 10 cancer types; however, we found significant or high heterogeneity for many cancer types. For example, heterogeneity was similarly high when the pooled HRs (95% CI) for overall mortality associated with visceral adiposity were essentially null as in 1.03 (0.55, 1.92; I2 = 58%) for breast, 0.99 (0.81, 1.21; I2 = 71%) for colorectal, versus when they demonstrated a potential increased risk 1.17 (0.85, 1.60; I2 = 78%) for hepatocellular carcinoma and 1.62 (0.90, 2.95; I2 = 84%) for renal cancer.Greater adiposity at diagnosis (directly measured by imaging) is not associated with worse survival among cancer survivors. However, heterogeneity and other potential limitations were noted across studies, suggesting differences in study design and adiposity measurement approaches, making interpretation of meta-analyses challenging. Future work to standardize imaging measurements and data analyses will strengthen research on the role of adiposity in cancer survival.CONCLUSIONGreater adiposity at diagnosis (directly measured by imaging) is not associated with worse survival among cancer survivors. However, heterogeneity and other potential limitations were noted across studies, suggesting differences in study design and adiposity measurement approaches, making interpretation of meta-analyses challenging. Future work to standardize imaging measurements and data analyses will strengthen research on the role of adiposity in cancer survival. PurposeThe increasing availability of clinical imaging tests (especially CT and MRI) that directly quantify adipose tissue has led to a rapid increase in studies examining the relationship of visceral, subcutaneous, and overall adiposity to cancer survival. To summarize this emerging body of literature, we conducted a systematic review and meta-analysis of imaging-measured as well as anthropometric proxies for adipose tissue distribution and cancer survival across a wide range of cancer types.MethodsUsing keywords related to adiposity, cancer, and survival, we conducted a systematic search of the literature in PubMed and MEDLINE, Embase, and Web of Science Core Collection databases from database inception to 30 June 2021. We used a random-effect method to calculate pooled hazard ratios (HR) and corresponding 95% confidence intervals (CI) within each cancer type and tested for heterogeneity using Cochran’s Q test and the I2 test.ResultsWe included 203 records for this review, of which 128 records were utilized for quantitative analysis among 10 cancer types: breast, colorectal, gastroesophageal, head and neck, hepatocellular carcinoma, lung, ovarian, pancreatic, prostate, and renal cancer. We found that imaging-measured visceral, subcutaneous, and total adiposity were not significantly associated with increased risk of overall mortality, death from primary cancer, or cancer progression among patients diagnosed with these 10 cancer types; however, we found significant or high heterogeneity for many cancer types. For example, heterogeneity was similarly high when the pooled HRs (95% CI) for overall mortality associated with visceral adiposity were essentially null as in 1.03 (0.55, 1.92; I2 = 58%) for breast, 0.99 (0.81, 1.21; I2 = 71%) for colorectal, versus when they demonstrated a potential increased risk 1.17 (0.85, 1.60; I2 = 78%) for hepatocellular carcinoma and 1.62 (0.90, 2.95; I2 = 84%) for renal cancer.ConclusionGreater adiposity at diagnosis (directly measured by imaging) is not associated with worse survival among cancer survivors. However, heterogeneity and other potential limitations were noted across studies, suggesting differences in study design and adiposity measurement approaches, making interpretation of meta-analyses challenging. Future work to standardize imaging measurements and data analyses will strengthen research on the role of adiposity in cancer survival. The increasing availability of clinical imaging tests (especially CT and MRI) that directly quantify adipose tissue has led to a rapid increase in studies examining the relationship of visceral, subcutaneous, and overall adiposity to cancer survival. To summarize this emerging body of literature, we conducted a systematic review and meta-analysis of imaging-measured as well as anthropometric proxies for adipose tissue distribution and cancer survival across a wide range of cancer types. Using keywords related to adiposity, cancer, and survival, we conducted a systematic search of the literature in PubMed and MEDLINE, Embase, and Web of Science Core Collection databases from database inception to 30 June 2021. We used a random-effect method to calculate pooled hazard ratios (HR) and corresponding 95% confidence intervals (CI) within each cancer type and tested for heterogeneity using Cochran's Q test and the I test. We included 203 records for this review, of which 128 records were utilized for quantitative analysis among 10 cancer types: breast, colorectal, gastroesophageal, head and neck, hepatocellular carcinoma, lung, ovarian, pancreatic, prostate, and renal cancer. We found that imaging-measured visceral, subcutaneous, and total adiposity were not significantly associated with increased risk of overall mortality, death from primary cancer, or cancer progression among patients diagnosed with these 10 cancer types; however, we found significant or high heterogeneity for many cancer types. For example, heterogeneity was similarly high when the pooled HRs (95% CI) for overall mortality associated with visceral adiposity were essentially null as in 1.03 (0.55, 1.92; I = 58%) for breast, 0.99 (0.81, 1.21; I = 71%) for colorectal, versus when they demonstrated a potential increased risk 1.17 (0.85, 1.60; I = 78%) for hepatocellular carcinoma and 1.62 (0.90, 2.95; I = 84%) for renal cancer. Greater adiposity at diagnosis (directly measured by imaging) is not associated with worse survival among cancer survivors. However, heterogeneity and other potential limitations were noted across studies, suggesting differences in study design and adiposity measurement approaches, making interpretation of meta-analyses challenging. Future work to standardize imaging measurements and data analyses will strengthen research on the role of adiposity in cancer survival. Purpose The increasing availability of clinical imaging tests (especially CT and MRI) that directly quantify adipose tissue has led to a rapid increase in studies examining the relationship of visceral, subcutaneous, and overall adiposity to cancer survival. To summarize this emerging body of literature, we conducted a systematic review and meta-analysis of imaging-measured as well as anthropometric proxies for adipose tissue distribution and cancer survival across a wide range of cancer types. Methods Using keywords related to adiposity, cancer, and survival, we conducted a systematic search of the literature in PubMed and MEDLINE, Embase, and Web of Science Core Collection databases from database inception to 30 June 2021. We used a random-effect method to calculate pooled hazard ratios (HR) and corresponding 95% confidence intervals (CI) within each cancer type and tested for heterogeneity using Cochran’s Q test and the I 2 test. Results We included 203 records for this review, of which 128 records were utilized for quantitative analysis among 10 cancer types: breast, colorectal, gastroesophageal, head and neck, hepatocellular carcinoma, lung, ovarian, pancreatic, prostate, and renal cancer. We found that imaging-measured visceral, subcutaneous, and total adiposity were not significantly associated with increased risk of overall mortality, death from primary cancer, or cancer progression among patients diagnosed with these 10 cancer types; however, we found significant or high heterogeneity for many cancer types. For example, heterogeneity was similarly high when the pooled HRs (95% CI) for overall mortality associated with visceral adiposity were essentially null as in 1.03 (0.55, 1.92; I 2 = 58%) for breast, 0.99 (0.81, 1.21; I 2 = 71%) for colorectal, versus when they demonstrated a potential increased risk 1.17 (0.85, 1.60; I 2 = 78%) for hepatocellular carcinoma and 1.62 (0.90, 2.95; I 2 = 84%) for renal cancer. Conclusion Greater adiposity at diagnosis (directly measured by imaging) is not associated with worse survival among cancer survivors. However, heterogeneity and other potential limitations were noted across studies, suggesting differences in study design and adiposity measurement approaches, making interpretation of meta-analyses challenging. Future work to standardize imaging measurements and data analyses will strengthen research on the role of adiposity in cancer survival. |
Author | Caan, Bette J. Cheng, En Cespedes Feliciano, Elizabeth M. Kirley, Jocelyn |
AuthorAffiliation | 1 Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA |
AuthorAffiliation_xml | – name: 1 Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA |
Author_xml | – sequence: 1 givenname: En surname: Cheng fullname: Cheng, En organization: Division of Research, Kaiser Permanente Northern California – sequence: 2 givenname: Jocelyn surname: Kirley fullname: Kirley, Jocelyn organization: Division of Research, Kaiser Permanente Northern California – sequence: 3 givenname: Elizabeth M. surname: Cespedes Feliciano fullname: Cespedes Feliciano, Elizabeth M. organization: Division of Research, Kaiser Permanente Northern California – sequence: 4 givenname: Bette J. orcidid: 0000-0002-5803-310X surname: Caan fullname: Caan, Bette J. email: bette.caan@kp.org organization: Division of Research, Kaiser Permanente Northern California |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35971021$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtr3DAUhUVJSSZp_0AWxdBNN06vZOvhbkrIq4VAN-1a3JGlVMGWppI9Zf59lJkkTbMIQuiCvnM40jkkeyEGS8gxhRMKID9nCpyzGljZVNCmlm_IgnJZBsb4HllAx2XNWdsckMOcbwGACwb75KDhnaTA6IKcn_Z-FbOfNhWGvjIYjE1VntPar3H4UmGVN3myI07eVMmuvf27BUc7YY0Bh032-R1563DI9v3DeUR-XV78PPtWX_-4-n52el2bVvKp7pUxVHAhl06hExSVcMbyblmyu7YMqEpiVNwI6ixteNtK2kLvOmO4E11zRL7ufFfzcrS9sWFKOOhV8iOmjY7o9f83wf_WN3GtKZQlJRSHTw8OKf6ZbZ706LOxw4DBxjlrJoF1kotGFfTjC_Q2zqm8eEspUBxoW6gPzyM9ZXn84QKoHWBSzDlZp42fym_G-4R-KNH0fZl6V6YuZeptmVoWKXshfXR_VdTsRLnA4camf7FfUd0BJDWw4A |
CitedBy_id | crossref_primary_10_3389_fimmu_2024_1419257 crossref_primary_10_3390_nu14224926 crossref_primary_10_1080_01635581_2024_2304691 crossref_primary_10_1042_CS20230411 crossref_primary_10_3390_jcm13020453 crossref_primary_10_1016_j_ypmed_2024_108021 crossref_primary_10_1016_j_acra_2024_01_013 crossref_primary_10_3390_cancers15041156 crossref_primary_10_1016_j_canep_2023_102436 crossref_primary_10_1371_journal_pone_0313577 crossref_primary_10_3390_nu15173810 crossref_primary_10_1002_cam4_70698 crossref_primary_10_1001_jamanetworkopen_2023_11673 crossref_primary_10_1007_s10549_024_07578_2 crossref_primary_10_3390_cancers17050846 crossref_primary_10_1097_NR9_0000000000000051 crossref_primary_10_1158_1055_9965_EPI_24_0306 crossref_primary_10_1186_s12885_024_12808_3 crossref_primary_10_3389_fviro_2023_1195717 crossref_primary_10_3390_diagnostics14222593 crossref_primary_10_1093_jnci_djae112 crossref_primary_10_1016_j_clnu_2023_03_024 crossref_primary_10_1136_bmjmed_2022_000339 crossref_primary_10_3390_genes14101963 crossref_primary_10_1158_1055_9965_EPI_23_0227 crossref_primary_10_1055_s_0044_1788887 crossref_primary_10_3390_cancers15041081 crossref_primary_10_1038_s41416_023_02470_0 crossref_primary_10_1007_s00104_024_02189_5 crossref_primary_10_1007_s00520_025_09200_7 crossref_primary_10_1002_jcsm_13673 |
Cites_doi | 10.1016/j.mjafi.2017.12.001 10.1245/s10434-014-4285-2 10.1038/pcan.2015.64 10.1016/j.ejca.2019.05.006 10.1016/S1470-2045(19)30797-1 10.1038/ijo.2016.171 10.1007/s12029-015-9709-0 10.1016/j.clnu.2020.05.019 10.1245/s10434-008-9891-4 10.1371/journal.pone.0122047 10.2307/2533446 10.1016/j.critrevonc.2021.103232 10.1038/s41391-019-0186-6 10.1016/j.ygyno.2013.03.003 10.2147/CMAR.S210958 10.1007/s10147-019-01559-y 10.1371/journal.pone.0169136 10.1002/jgh3.12167 10.1016/j.clinimag.2018.05.006 10.1002/jcsm.12274 10.1007/s00268-015-3038-0 10.1002/ijc.23747 10.1016/j.lungcan.2016.10.017 10.1093/ije/dyp334 10.3390/cancers12061605 10.3390/jcm8091358 10.14740/wjon1225 10.1097/MD.0000000000013878 10.1158/1055-9965.EPI-17-0200 10.1186/s12885-019-5319-8 10.1016/j.clnu.2017.05.017 10.1245/s10434-015-4432-4 10.1016/j.oraloncology.2020.104771 10.1016/j.crad.2018.07.094 10.1016/j.ejogrb.2020.11.050 10.1016/j.juro.2014.03.107 10.1159/000493586 10.1007/s11605-020-04716-1 10.1016/j.ejca.2015.07.042 10.1038/s41598-017-07320-7 10.1016/j.ijsu.2014.01.010 10.1093/annonc/mdu042 10.1002/jcsm.12524 10.1016/j.gore.2019.100502 10.1001/jamanetworkopen.2021.3520 10.1016/j.ejca.2015.01.003 10.1097/COC.0000000000000388 10.1007/s00432-014-1893-y 10.1245/s10434-012-2301-y 10.4143/crt.2017.232 10.1002/ijc.31049 10.3390/cancers13040608 10.2147/CMAR.S167417 10.1007/s00261-017-1418-7 10.1007/s00330-020-07294-7 10.1007/s10552-015-0635-z 10.1016/j.clinimag.2021.03.035 10.1002/pros.24054 10.1097/MD.0000000000001269 10.1016/j.juro.2014.11.088 10.1245/s10434-018-6624-1 10.1002/hed.26310 10.21037/tcr-20-2974 10.1007/s10549-020-05617-2 10.3389/fonc.2021.679158 10.18632/oncotarget.24210 10.1002/hed.25605 10.1016/j.athoracsur.2019.10.064 10.1139/H08-075 10.1186/s12885-019-5837-4 10.1186/s40064-015-1659-2 10.1111/j.1477-2574.2011.00304.x 10.1007/s12020-015-0525-x 10.1158/1940-6207.CAPR-12-0048 10.3390/cancers12071986 10.1002/jcsm.12484 10.5489/cuaj.4923 10.1007/s00330-019-06630-w 10.3389/fmolb.2020.610229 10.1016/S1470-2045(08)70153-0 10.1002/jso.22031 10.1111/ans.16708 10.2147/CMAR.S230973 10.1007/s11912-016-0539-4 10.1007/s11605-018-3802-1 10.1159/000486143 10.3322/canjclin.27.4.205 10.1158/1055-9965.EPI-16-0559 10.1016/j.hpb.2020.04.004 10.1097/JU.0000000000001321 10.1007/s13668-019-00280-6 10.1111/codi.14793 10.1002/jcsm.12155 10.21037/qims.2020.02.09 10.1016/j.soard.2020.10.022 10.14740/wjon1289 10.1097/MCO.0000000000000395 10.1016/j.ygyno.2021.02.032 10.1111/j.1743-7563.2011.01512.x 10.1245/s10434-016-5668-3 10.1002/ijc.27639 10.1136/gut.2009.188946 10.1007/s10552-014-0450-y 10.1097/MD.0000000000003305 10.3322/caac.21708 10.21037/jgo.2017.07.03 10.1111/ecc.12611 10.1016/j.clnesp.2016.04.001 10.1007/s11605-010-1297-5 10.1148/radiol.2019181796 10.3390/nu6115280 10.3390/cancers12010060 10.1093/jnci/djt310 10.3945/ajcn.2009.28385 10.1111/j.1467-789X.2011.00917.x 10.1634/theoncologist.2010-0227 10.1634/theoncologist.2011-0213 10.1002/ijc.30158 10.1007/s00423-018-1722-x 10.1038/s41598-021-91449-z 10.1136/gut.2008.164053 10.1007/s12032-017-0908-3 10.1371/journal.pone.0242785 10.1371/journal.pone.0218136 10.1038/s41430-017-0032-7 10.1158/0008-5472.CAN-17-3287 10.1038/s41598-021-90187-6 10.1097/JU.0000000000001377 10.1371/journal.pone.0238649 10.1158/1055-9965.EPI-06-0356 10.1097/IGC.0000000000001165 10.1093/jnci/djz150 10.1161/CIR.0b013e318233bc6a 10.1002/bjs.10075 10.1002/jcsm.12234 10.1038/sj.ijo.0800741 10.1158/1055-9965.EPI-17-0144 10.1016/j.critrevonc.2015.06.002 10.1152/japplphysiol.00744.2004 10.1038/bjc.2013.666 10.1016/j.jhep.2015.02.031 10.1002/cncr.28218 10.1002/jcsm.12358 10.18632/oncotarget.24500 10.1016/j.nut.2020.111135 10.1158/1078-0432.CCR-12-2603 10.1016/j.clml.2016.04.010 10.1093/aje/kwt233 10.1016/j.jamcollsurg.2013.01.007 10.1002/oby.22458 10.1007/s11605-017-3618-4 10.1007/s00330-015-3963-1 10.1007/s11605-012-2045-9 10.1007/s11605-018-3695-z 10.1002/ijc.30459 10.1007/s00520-017-3902-6 10.1007/s00330-014-3110-4 10.1007/s00384-018-3038-2 10.1093/ajcn/64.3.449S 10.1148/radiol.2018171504 10.1007/s10549-019-05467-7 10.1007/s00423-020-01901-3 10.1093/jjco/hyu193 10.1016/j.tipsro.2020.10.001 10.1158/1055-9965.EPI-19-1134 10.3346/jkms.2016.31.10.1571 10.1038/ejcn.2012.166 10.1002/cam4.571 10.1007/978-3-319-21416-0 10.1177/0284185120918373 10.1080/21623945.2018.1525252 10.1002/ijc.30163 10.1158/1055-9965.EPI-20-0737 10.1158/1055-9965.EPI-10-0522 10.1007/s00268-012-1581-5 10.3389/fonc.2020.00558 10.18632/oncotarget.21917 10.3390/jcm10051079 10.1002/jso.23366 10.1080/0284186X.2020.1744716 10.1136/jitc-2020-000821 10.1007/s005200100268 10.4143/crt.2019.249 10.1007/s00277-015-2571-0 10.1097/MD.0000000000010988 10.1158/1940-6207.CAPR-10-0229 10.1016/j.ejso.2018.09.007 10.1007/s11605-015-2834-z 10.1016/j.clnu.2020.11.007 10.1371/journal.pone.0118022 10.1097/EDE.0000000000000493 10.1016/j.dld.2015.07.001 10.1186/s12957-020-02006-3 10.4048/jbc.2020.23.e8 10.1136/gut.2005.068189 10.1016/j.suronc.2021.101606 10.1038/ejcn.2017.70 10.1136/bmj.327.7414.557 10.1159/000318988 10.3102/1076998609346961 10.1186/s12916-019-1443-1 10.3389/fcvm.2020.00022 10.1016/j.suronc.2015.09.002 10.1007/s00423-021-02092-1 10.1007/s10552-020-01306-z 10.1200/JCO.2011.36.2723 10.1093/annonc/mdx819 10.1002/ijc.29238 10.1245/s10434-015-4796-5 10.1038/s41574-021-00487-0 10.1007/s10549-010-0990-0 10.1002/pros.24088 10.3390/cancers11111655 10.3390/jcm8101672 10.1080/01635581.2014.867065 10.1016/j.cgh.2015.09.036 10.1002/jcsm.12357 10.1007/s10549-014-3048-x 10.1016/j.hbpd.2018.07.008 10.1016/0197-2456(86)90046-2 10.1002/cam4.1365 10.1177/0284185117723370 10.1111/iju.12716 10.1093/aje/kwg236 10.1245/s10434-014-3686-6 10.12659/MSM.894202 10.1080/2162402X.2019.1580128 10.1038/bjc.2017.440 10.1007/s10552-018-1042-z 10.1159/000488779 10.1634/theoncologist.2019-0590 10.1111/liv.14755 10.1016/j.ygyno.2014.01.031 10.1007/s12185-021-03122-w 10.1136/bmj.n71 10.1093/aje/kwj017 10.14740/wjon1244 10.1080/01635581.2016.1134600 10.1097/DCR.0000000000001352 10.1158/1055-9965.EPI-16-0764 10.1111/jog.14560 10.1007/978-3-662-58254-1_37 10.1186/s12885-019-6086-2 10.1007/s10549-018-4915-7 10.1245/s10434-017-6077-y 10.3390/cancers12123602 10.1016/j.juro.2018.01.069 10.1016/j.healthplace.2015.10.003 10.1097/JU.0000000000001428 10.1007/s10552-015-0673-6 10.1001/jamaoncol.2018.0137 10.1002/ijc.28841 10.1007/s00268-017-4255-5 10.1002/jcsm.12540 10.1007/s00330-018-5723-5 10.7150/jca.37270 10.1056/NEJMsr1606602 10.1016/j.ijsu.2017.01.075 10.1002/bjs.7823 10.1016/j.jss.2014.12.048 10.1136/bmj.d4002 10.1155/2021/6657566 10.1515/hmbci-2015-0075 10.1186/s12916-020-01733-4 10.1016/j.urolonc.2017.12.011 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TO 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM |
DOI | 10.1007/s10552-022-01613-7 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Oncogenes and Growth Factors Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1573-7225 |
EndPage | 1246 |
ExternalDocumentID | PMC10101770 35971021 10_1007_s10552_022_01613_7 |
Genre | Meta-Analysis Systematic Review Journal Article |
GrantInformation_xml | – fundername: National Institutes of Health grantid: K01CA226155; R01CA251589 funderid: http://dx.doi.org/10.13039/100000002 – fundername: NIH HHS grantid: K01CA226155 – fundername: NIA NIH HHS grantid: R01 AG065334 – fundername: NCI NIH HHS grantid: R01 CA251589 – fundername: NIH HHS grantid: R01CA251589 – fundername: NCI NIH HHS grantid: R01 CA240394 – fundername: NCI NIH HHS grantid: K01 CA226155 |
GroupedDBID | --- -4W -5E -5G -BR -EM -Y2 -~C .86 .VR 04C 06C 06D 0R~ 0VY 199 1N0 1SB 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AACGO AAHNG AAIAL AAJBT AAJKR AANCE AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBHK ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABPLY ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTLG ABTMW ABULA ABUWG ABWNU ABXPI ABXSQ ACAOD ACDTI ACGFS ACHIC ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADULT ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEUPB AEVLU AEXYK AEXZC AFBBN AFEXP AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG AQVQM ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DCCCD DDRTE DL5 DNIVK DOOOF DPUIP DU5 EBD EBLON EBS EIHBH EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HGD HMCUK HMJXF HQ3 HQYDN HRMNR HTVGU HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IPSME ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JAAYA JBMMH JBSCW JCJTX JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST JZLTJ KDC KOV KOW KPH LAK LLZTM M1P M4Y MA- N2Q NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SA0 SAP SBY SCLPG SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 WOW YLTOR Z45 Z7U Z7W Z81 Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~A9 ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG ADQXQ AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY 7TO 7XB 8FK H94 K9. PKEHL PQEST PQUKI PUEGO 7X8 5PM |
ID | FETCH-LOGICAL-c475t-d8cc16567bf8af61a86fce59b613f4e59a8095a85c61fe135447140df9cc5f693 |
IEDL.DBID | 7X7 |
ISSN | 0957-5243 1573-7225 |
IngestDate | Thu Aug 28 05:00:53 EDT 2025 Tue Aug 05 11:00:53 EDT 2025 Sat Aug 23 14:06:37 EDT 2025 Mon Jul 21 06:05:18 EDT 2025 Tue Jul 01 03:00:18 EDT 2025 Thu Apr 24 22:59:55 EDT 2025 Fri Feb 21 02:45:00 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Waist–hip ratio Adiposity Computed tomography Survival Body composition Cancer |
Language | English |
License | 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c475t-d8cc16567bf8af61a86fce59b613f4e59a8095a85c61fe135447140df9cc5f693 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 All authors contributed to the study conception and design. En Cheng, Jocelyn Kirley, and Elizabeth M. Cespedes Feliciano participated in the literature search and screening. En Cheng and Jocelyn Kirley performed study quality assessment. En Cheng conducted data analysis. En Cheng and Bette Caan drafted the manuscript. All authors critically revised the manuscript for important intellectual content and approved the final manuscript. Author Contributions Contributed equally |
ORCID | 0000-0002-5803-310X |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/10101770 |
PMID | 35971021 |
PQID | 2708085014 |
PQPubID | 31057 |
PageCount | 28 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10101770 proquest_miscellaneous_2702975638 proquest_journals_2708085014 pubmed_primary_35971021 crossref_citationtrail_10_1007_s10552_022_01613_7 crossref_primary_10_1007_s10552_022_01613_7 springer_journals_10_1007_s10552_022_01613_7 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-10-01 |
PublicationDateYYYYMMDD | 2022-10-01 |
PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Netherlands – name: Dordrecht |
PublicationSubtitle | An International Journal of Studies of Cancer in Human Populations |
PublicationTitle | Cancer causes & control |
PublicationTitleAbbrev | Cancer Causes Control |
PublicationTitleAlternate | Cancer Causes Control |
PublicationYear | 2022 |
Publisher | Springer International Publishing Springer Nature B.V |
Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
References | Peng, Wu, Tien, Lu, Wang, Chen (CR153) 2021; 31 Popinat, Cousse, Goldfarb (CR136) 2019; 8 Gadekar, Dudeja, Basu, Vashisht, Mukherji (CR50) 2020; 76 Stangl-Kremser, Suarez-Ibarrola, Andrea (CR163) 2020; 23 George, Bernstein, Smith (CR239) 2014; 146 Choi, Park, Jeong (CR21) 2013; 132 Shirdel, Andersson, Myte (CR93) 2020; 59 Hollander, Kampman, van Herpen (CR26) 2015; 96 Antoun, Bayar, Ileana (CR154) 2015; 51 CR278 Lee, Lee, Ha (CR159) 2018; 200 CR277 Clark, Siegel, Chen (CR79) 2013; 216 Cloyd, Nogueras-González, Prakash (CR203) 2018; 22 Gregg, Surasi, Childs (CR158) 2021; 205 Yoon, Chung, Lim, Kim (CR96) 2019; 29 Xu, Huelster, Hatcher (CR231) 2021; 205 Chung, Lee, Cho (CR78) 2019; 12 Sperrin, Candlish, Badrick, Renehan, Buchan (CR273) 2016; 27 Elia (CR42) 2013; 67 Wochner, Clauss, Nattenmueller (CR149) 2020; 15 Park, Han, Cho (CR260) 2014; 66 CR168 Torres, Hartmann, Cliby (CR140) 2013; 129 van Dijk, Krill, Farshidfar (CR229) 2019; 10 Zhang, Cai, Bao (CR247) 2017 Pan, Chen, Yang (CR190) 2021; 11 Choe, Park, Ryoo, Moon, Oh, Han (CR76) 2016; 31 Taki, Sato, Nakatani (CR108) 2021; 406 Naumann, Eberlein, Farnia (CR146) 2019; 11 Majumder, Gupta, Arora, Singh, Singh (CR28) 2016; 14 Imai, Takai, Maeda (CR130) 2018; 9 Schwarzer, Carpenter, Rücker (CR57) 2015 Nault, Pigneur, Nelson (CR126) 2015; 47 Rodrigues, Landi, Castro (CR220) 2021; 25 Minami, Ihara, Tanaka, Komuta (CR135) 2020; 11 Iwase, Parikh, Dibaj (CR66) 2021; 13 Perrin, Lenfant, Boisson, Bert, Rat, Facy (CR91) 2021; 17 Katsui, Ogata, Sugiyama (CR208) 2021; 11 Buechel, Enserro, Burger (CR202) 2021; 161 Higashi, Hayashi, Kaida (CR120) 2015; 22 Kocarnik, Chan, Slattery (CR276) 2016; 139 Wu, Liu, Chaftari (CR164) 2015; 10 Caan, Cespedes Feliciano, Prado (CR62) 2018; 4 Ferrigno, Buccheri (CR258) 2001; 9 Bagheri, Speakman, Shemirani, Djafarian (CR18) 2016; 40 Abrahamson, Gammon, Lund (CR235) 2006; 15 He, Jiang, Liu (CR185) 2020; 108 Dal Maso, Zucchetto, Talamini (CR238) 2008; 123 Kobayashi, Kaido, Hamaguchi (CR85) 2018; 42 Gursoy Coruh, Uzun, Akkaya (CR101) 2021; 76 Zhang, Folsom, Sellers, Kushi, Potter (CR248) 1995; 76 Zhao, Zhang, Mei (CR38) 2018; 44 Jackson, Tulloch-Reid, McCaw-Binns (CR255) 2020; 31 Booth, Magnuson, Fouts (CR264) 2018; 7 Goodwin, Ennis, Pritchard (CR240) 2012; 30 Kroh, Uschner, Lodewick (CR124) 2019; 18 Zhang, Yang, Luo (CR37) 2013; 109 Brown, Caan, Prado (CR201) 2020; 112 Brown (CR3) 2021; 17 Ha, Kim, Han (CR206) 2018; 50 Sterne, Sutton, Ioannidis (CR60) 2011; 343 Kim, Chung, Park (CR152) 2016; 68 Prado, Lieffers, McCargar (CR47) 2008; 9 Jung, Roh, Kim (CR114) 2019; 116 Magri, Gottfried, Di Segni (CR137) 2019; 11 Howe, Subbaramaiah, Hudis, Dannenberg (CR5) 2013; 19 His, Fagherazzi, Mesrine, Boutron-Ruault, Clavel-Chapelon, Dossus (CR241) 2016; 139 Siegel, Miller, Fuchs, Jemal (CR2) 2022; 72 Gu, Zhu, Wang (CR205) 2015; 10 Liu, Xu (CR259) 2015; 21 Steffens, Gruenwald, Ringe (CR177) 2011; 16 Page, McKenzie, Bossuyt (CR17) 2021; 372 Yip, Goh, Davies (CR49) 2014; 24 Choi, Yoon, Lee (CR150) 2018; 9 Kim, Doan, He, Lau, Pleass, Patel (CR27) 2021; 205 Chait, den Hartigh (CR263) 2020; 7 Naya, Zenbutsu, Araki (CR174) 2010; 85 Shariff-Marco, Gomez, Sangaramoorthy (CR243) 2015; 36 Okumura, Kaido, Hamaguchi (CR147) 2017; 24 Tokunaga, Nakagawa, Miyamoto (CR94) 2020; 22 Huang, Yang, Chen (CR142) 2020; 11 Saeed, Shridhar, Almhanna, Hoffe, Chuong, Meredith (CR113) 2017; 8 Kuritzkes, Pappou, Kiran (CR209) 2018; 33 Cole, Platt, Schisterman (CR271) 2010; 39 Deurenberg, Yap, van Staveren (CR9) 1998; 22 McSorley, Black, Horgan, McMillan (CR89) 2018; 37 Ferguson, Mitzman, Derstine (CR131) 2020; 109 Basile, Bartoletti, Polano (CR71) 2021; 40 Ying, Jin, Wu, Cai (CR233) 2021; 2021 Zhang, Li, Jiang (CR110) 2021; 85 Sun, Nichols, Robinson, Sherman, Olshan, Troester (CR244) 2015; 26 Zhong, Yan, Wu (CR39) 2016; 19 Sasaki, Sugino, Kato, Nishikawa, Kanda (CR162) 2020; 25 Kobayashi, Kawai, Nakano (CR123) 2018; 10 Park, Kim, Beom (CR107) 2018; 25 von Hessen, Roumet, Maurer (CR230) 2021; 41 Di Bella, Howard, Oyekunle (CR157) 2020; 80 Hakimi, Furberg, Zabor (CR265) 2013; 105 DerSimonian, Laird (CR56) 1986; 7 Minami, Ihara, Nishimatsu, Komuta (CR134) 2019; 10 Nguyen, Mellnick, Yim, Salter, Ippolito (CR175) 2018; 287 Tao, Shu, Ruan, Gao, Zheng (CR245) 2006; 163 Tamandl, Paireder, Asari, Baltzer, Schoppmann, Ba-Ssalamah (CR226) 2016; 26 Ruiz, Colley, Hamilton (CR53) 1971; 25 Park, Koo, Chung (CR218) 2020; 12 Deurenberg (CR41) 1996; 64 Gonzalez, Correia, Heymsfield (CR13) 2017; 20 Itoh, Shirabe, Matsumoto (CR121) 2014; 21 Fujiwara, Nakagawa, Kudo (CR118) 2015; 63 CR16 Franzoi, Vandeputte, Eiger (CR64) 2020; 181 Kim, Chin, Hwang, Jun (CR104) 2014; 12 McDonald, Fiveash, Kirkland (CR212) 2017; 35 Ryu, Shin, Kim (CR148) 2020; 22 Xiao, Mazurak, Olobatuyi, Caan, Prado (CR267) 2018; 27 Ejaz, Spolverato, Kim (CR22) 2015; 195 Deluche, Leobon, Desport, Venat-Bouvet, Usseglio, Tubiana-Mathieu (CR63) 2018; 26 Celik, Kizildag Yirgin, Goksever Celik (CR179) 2021; 47 Chen (CR4) 2011; 12 Addo, Himes (CR52) 2010; 91 Cornier, Despres, Davis (CR275) 2011; 124 van Vledder, Levolger, Ayez, Verhoef, Tran, Ijzermans (CR95) 2012; 99 Kays, Koniaris, Cooper (CR170) 2020; 12 Dai, Zhang, Liu (CR167) 2020; 12 Balentine, Enriquez, Fisher (CR45) 2010; 14 Gupta, Majumder, Arora (CR25) 2016; 102 Donkers, Fasmer, McGrane (CR182) 2021; 256 Mizuno, Miyajima, Hibi (CR173) 2017 Yamamoto, Fujii, Sato (CR232) 2012; 8 Bachmann, Leonard, Nachit (CR197) 2018; 81 Boutin, Katz, Chaudhari (CR178) 2020; 10 Sugimoto, Farnell, Nagorney (CR225) 2018; 22 Dong, Cai, Zhang (CR99) 2021; 40 Frostberg, Pedersen, Manhoobi, Rahr, Rafaelsen (CR81) 2021; 62 Grąt, Pacho, Grąt, Krawczyk, Zieniewicz, Rowiński (CR129) 2019; 8 Carcamo, Penailillo, Bellolio (CR73) 2021; 91 Choi, Kim, Hwang, Byun (CR98) 2018; 97 Iwase, Sangai, Fujimoto (CR207) 2020; 179 Anjanappa, Corden, Green (CR262) 2020; 16 Begg, Mazumdar (CR61) 1994; 50 Sabel, Terjimanian, Conlon (CR221) 2013; 108 Mason, Boorjian, Bhindi (CR160) 2018; 12 Zhang, Chen, Li, Xu, Song, Wang (CR36) 2018; 9 Kwan, John, Caan (CR242) 2014; 179 Catanese, Aringhieri, Vivaldi (CR97) 2021; 10 Psutka, Boorjian, Moynagh (CR192) 2015; 193 Mayeda, Glymour (CR272) 2017; 26 Okumura, Kaido, Hamaguchi (CR189) 2017; 24 Han, Ryu, Park (CR83) 2020; 52 Miller, Ignatoski, Daignault (CR188) 2012; 36 Antoun, Bayar, Dyevre, Lanoy, Smolenschi, Ducreux (CR196) 2019; 19 Theologides (CR269) 1977; 27 Higgins, Thompson, Deeks, Altman (CR58) 2003; 327 Lee, Lee, Na, Lee (CR132) 2018; 50 Mauland, Eng, Ytre-Hauge (CR187) 2017; 8 van Baar, Winkels, Brouwer (CR227) 2020; 29 Blanc-Durand, Campedel, Mule (CR200) 2020; 30 Erbaycu, Kazanci, Biçmen (CR257) 2010; 30 Dolan, Almasaudi, Dieu, Horgan, McSorley, McMillan (CR80) 2019; 10 Borugian, Sheps, Kim-Sing (CR236) 2003; 158 CR43 Hagens, Feenstra, van Egmond (CR102) 2020; 11 Cavagnari, Silva, Pereira (CR74) 2019; 19 Pai, Chuang, Chuang (CR116) 2018; 7 Ebadi, Mazurak (CR270) 2014; 6 Choi, Oh, Lee, Oh, Won (CR77) 2018; 9 Lee, Murphy, McMahon (CR86) 2015; 46 Papoulas, Weiser, Rosen (CR191) 2015; 39 Li, Tang, Chen, Li, Zhang, Sun (CR105) 2015; 141 Cushen, Power, Murphy (CR156) 2016; 13 Park, Lee, Kim (CR176) 2014; 192 Jayasekara, English, Haydon (CR251) 2018; 142 Ballian, Lubner, Munoz (CR198) 2012; 105 Lennon, Sperrin, Badrick, Renehan (CR8) 2016; 18 CR59 Schaffler-Schaden, Mittermair, Birsak (CR222) 2020; 405 Yoo, Lee, Lee, Baek, Ahn (CR234) 2018; 43 Choi, Park, Lee (CR40) 2018; 29 Zimmermann, Delouya, Barkati, Campeau, Rompotinos, Taussky (CR165) 2016; 26 CR54 Saeki, Yamasaki, Maeda (CR127) 2019; 14 Sawada, Saitho, Hayashi (CR128) 2019; 3 CR51 Miyamoto, Oki, Emi (CR90) 2018; 38 Young, Quach, Song (CR195) 2020; 8 Gillen, Mills, Dvorak (CR183) 2019; 30 Sheikhbahaei, Reyes, Rowe, Pienta (CR223) 2021; 81 Moller, Roswall, Van Hemelrijck (CR256) 2015; 136 Hopkins, Reif, Bigam, Baracos, Eurich, Sawyer (CR84) 2019; 62 Fedirko, Romieu, Aleksandrova (CR249) 2014; 135 Chan, Vieira, Aune (CR20) 2014; 25 Rickles, Iannuzzi, Mironov (CR92) 2013; 17 Wang, Ma, Chen (CR109) 2018; 72 Bian, Dai, Feng (CR199) 2018; 97 Shen, Punyanitya, Wang (CR15) 1985; 97 Charette, Vandeputte, Ameye (CR75) 2019; 19 Zhang, Coletta, Allen (CR141) 2018; 28 Jang, Choi, Hwang (CR122) 2021; 10 Wang, Xu, Zhou (CR34) 2018; 72 Hamaguchi, Kaido, Okumura (CR119) 2019; 8 Grignol, Smith, Shlapak, Zhang, Del Campo, Carson (CR184) 2015; 24 Shi, Yang, Du (CR33) 2016; 95 Moon, Ju, Jeong (CR213) 2008; 15 Okamura, Watanabe, Yamashita (CR106) 2018; 403 Slaughter, Thai, Penaroza (CR139) 2014; 133 Hacker, Hasenclever, Linder (CR112) 2020; 11 Mathur, Hernandez, Shaheen (CR261) 2011; 13 Malietzis, Currie, Athanasiou (CR88) 2016; 103 Zhou, Tseng, Guo (CR111) 2021; 30 Akhter, Pauyo, Khan, Musahl, Karlsson, Hirschmann (CR268) 2019 Pak, Kim, Park, Kim, Lee, Joung (CR161) 2020 Cooper, Slack, Fogelman (CR151) 2015; 22 Ohki, Tateishi, Shiina (CR216) 2009; 58 Ohwaki, Endo, Hattori (CR217) 2015; 51 Huh, Park, Lee (CR65) 2020; 23 Prizment, Flood, Anderson, Folsom (CR252) 2010; 19 Fahey, Mallitt, Astell-Burt, Stone, Whiteman (CR23) 2015; 26 Farris, Courneya, Kopciuk, McGregor, Friedenreich (CR254) 2018; 118 Kaneko, Miyajima, Yuge (CR169) 2015; 45 Lee, Jeong, Seo (CR172) 2015; 22 Petrelli, Cortellini, Indini (CR29) 2021; 4 Nattenmueller, Wochner, Muley (CR214) 2017; 12 Guiu, Petit, Bonnetain (CR82) 2010; 59 Minami, Ihara, Komuta (CR133) 2020; 11 Lauby-Secretan, Scoccianti, Loomis (CR1) 2016; 375 Caan, Kroenke (CR10) 2017; 26 Cao, Ma (CR19) 2011; 4 Wisse, Tryggvadottir, Simonsson (CR246) 2018; 29 Jaspan, Lin, Popov (CR274) 2021; 159 Lee, Kim, Lee, Han, Lee, Lee (CR210) 2019; 8 Chakedis, Spolverato, Beal (CR180) 2018; 22 Mallet, Decazes, Modzelewski (CR44) 2021; 11 Takeoka, Sakatoku, Miura (CR194) 2016; 16 Shachar, Williams (CR11) 2017; 26 Gupta, Das, Majumder (CR24) 2018; 41 McMillan, Sattar, McArdle (CR6) 2006; 333 Lee, Giovannucci (CR7) 2019; 8 Lee, Ban, Park, Lee (CR115) 2019; 41 Wang, Khankari, Cai (CR253) 2017; 140 Xu, Hu, Anwaier (CR46) 2021 Protani, Nagle, Webb (CR31) 2012; 5 De Amorim, Bos, Veld, Lozano-Calderon, Torriani, Bredella (CR181) 2018; 59 Iwase, Sangai, Nagashima (CR67) 2016; 5 Protani, Coory, Martin (CR30) 2010; 123 Antoun, Lanoy, Iacovelli (CR166) 2013; 119 Feng, Huang, Zhao (CR100) 2020; MG van Vledder (1613_CR95) 2012; 99 1613_CR16 S Catanese (1613_CR97) 2021; 10 MS Sabel (1613_CR221) 2013; 108 V Jaspan (1613_CR274) 2021; 159 W Shen (1613_CR15) 1985; 97 MA Franzoi (1613_CR64) 2020; 181 M Dewey (1613_CR14) 2019; 291 B Guiu (1613_CR82) 2010; 59 L von Hessen (1613_CR230) 2021; 41 QT Dong (1613_CR99) 2021; 40 AE Prizment (1613_CR252) 2010; 19 ML Kwan (1613_CR242) 2014; 179 CM Prado (1613_CR47) 2008; 9 S Pak (1613_CR161) 2020 P Deurenberg (1613_CR41) 1996; 64 Y Miyamoto (1613_CR90) 2018; 38 JH Kim (1613_CR104) 2014; 12 ER Mayeda (1613_CR272) 2017; 26 H-l Chen (1613_CR237) 2016; 5 M Bagheri (1613_CR18) 2016; 40 J Dai (1613_CR167) 2020; 12 A Kobayashi (1613_CR85) 2018; 42 SW Park (1613_CR219) 2015; 19 S Shariff-Marco (1613_CR243) 2015; 36 K Imai (1613_CR130) 2018; 9 S Minami (1613_CR135) 2020; 11 BS Miller (1613_CR188) 2012; 36 N Charette (1613_CR75) 2019; 19 H van Baar (1613_CR227) 2020; 29 MS Farris (1613_CR254) 2018; 118 T Iwase (1613_CR67) 2016; 5 R Mizuno (1613_CR173) 2017 PC Pai (1613_CR116) 2018; 7 CJ Balentine (1613_CR45) 2010; 14 ID Yoo (1613_CR234) 2018; 43 YH Park (1613_CR176) 2014; 192 S Antoun (1613_CR154) 2015; 51 AD Booth (1613_CR264) 2018; 7 R DerSimonian (1613_CR56) 1986; 7 AA Hakimi (1613_CR265) 2013; 105 E Celik (1613_CR179) 2021; 47 KK Mauland (1613_CR187) 2017; 8 A Mathur (1613_CR261) 2011; 13 A Gupta (1613_CR25) 2016; 102 1613_CR43 W Clark (1613_CR79) 2013; 216 Y Pan (1613_CR190) 2021; 11 P Deurenberg (1613_CR9) 1998; 22 N Fujiwara (1613_CR118) 2015; 63 S Steffens (1613_CR177) 2011; 16 YC Peng (1613_CR153) 2021; 31 PP Fahey (1613_CR23) 2015; 26 MH Choi (1613_CR77) 2018; 9 S Akhter (1613_CR268) 2019 1613_CR59 S Zhong (1613_CR39) 2016; 19 L Ruiz (1613_CR53) 1971; 25 S Gaujoux (1613_CR143) 2012; 19 CM Di Bella (1613_CR157) 2020; 80 M Ebadi (1613_CR270) 2014; 6 1613_CR51 1613_CR54 HS Park (1613_CR107) 2018; 25 T Higashi (1613_CR120) 2015; 22 JC Valentine (1613_CR55) 2010; 35 AM McDonald (1613_CR212) 2017; 35 D Hollander (1613_CR26) 2015; 96 JS Lee (1613_CR159) 2018; 200 SR Cole (1613_CR271) 2010; 39 B Zhao (1613_CR38) 2018; 44 SJ Cushen (1613_CR156) 2016; 13 DY Shin (1613_CR193) 2016; 95 M His (1613_CR241) 2016; 139 GK Nguyen (1613_CR175) 2018; 287 V Magri (1613_CR137) 2019; 11 M Sperrin (1613_CR273) 2016; 27 R Bachmann (1613_CR197) 2018; 81 A Ejaz (1613_CR22) 2015; 195 CY Huang (1613_CR142) 2020; 11 AC Young (1613_CR195) 2020; 8 J Chen (1613_CR4) 2011; 12 K Majumder (1613_CR28) 2016; 14 BJ Caan (1613_CR62) 2018; 4 Y Taki (1613_CR108) 2021; 406 DC McMillan (1613_CR6) 2006; 333 R Tokunaga (1613_CR94) 2020; 22 D Basile (1613_CR71) 2021; 40 SM George (1613_CR239) 2014; 146 S Antoun (1613_CR166) 2013; 119 X Rong (1613_CR32) 2015; 94 H Moller (1613_CR256) 2015; 136 AS Rickles (1613_CR92) 2013; 17 T Ohki (1613_CR216) 2009; 58 ERC Hagens (1613_CR102) 2020; 11 M Zimmermann (1613_CR165) 2016; 26 D Tamandl (1613_CR226) 2016; 26 A Sanchez (1613_CR266) 2020; 21 1613_CR168 N Wang (1613_CR253) 2017; 140 HG Moon (1613_CR213) 2008; 15 Y-Q Shi (1613_CR33) 2016; 95 M Shirdel (1613_CR93) 2020; 59 L Dal Maso (1613_CR238) 2008; 123 RJ Mason (1613_CR160) 2018; 12 JM Cloyd (1613_CR203) 2018; 22 A Theologides (1613_CR269) 1977; 27 N Ballian (1613_CR198) 2012; 105 PJ Goodwin (1613_CR240) 2012; 30 MJ Zhou (1613_CR111) 2021; 30 WZ He (1613_CR185) 2020; 108 G Kaneko (1613_CR169) 2015; 45 K Sawada (1613_CR128) 2019; 3 S Wu (1613_CR35) 2014; 25 MAV Cavagnari (1613_CR74) 2019; 19 SP Psutka (1613_CR192) 2015; 193 CB Begg (1613_CR61) 1994; 50 J Huh (1613_CR65) 2020; 23 CS Lee (1613_CR86) 2015; 46 W Wu (1613_CR164) 2015; 10 1613_CR277 1613_CR278 S Ladoire (1613_CR171) 2011; 16 K Grąt (1613_CR129) 2019; 8 G Schwarzer (1613_CR57) 2015 E Chung (1613_CR78) 2019; 12 S Itoh (1613_CR121) 2014; 21 J Lee (1613_CR144) 2020; 15 S Antoun (1613_CR196) 2019; 19 J Chakedis (1613_CR180) 2018; 22 V Rodrigues (1613_CR220) 2021; 25 JA Sterne (1613_CR60) 2011; 343 SL Wang (1613_CR109) 2018; 72 S Minami (1613_CR133) 2020; 11 MH Choi (1613_CR98) 2018; 97 C Yip (1613_CR49) 2014; 24 HW Lee (1613_CR172) 2015; 22 J Xiao (1613_CR267) 2018; 27 P Ying (1613_CR233) 2021; 2021 DPJ van Dijk (1613_CR229) 2019; 10 MD Jackson (1613_CR255) 2020; 31 W Feng (1613_CR100) 2020; 11 R Mallet (1613_CR44) 2021; 11 LR Howe (1613_CR5) 2013; 19 DSM Chan (1613_CR20) 2014; 25 UT Hacker (1613_CR112) 2020; 11 J Nattenmueller (1613_CR214) 2017; 12 J Jung (1613_CR186) 2021; 114 S Okumura (1613_CR147) 2017; 24 P Blanc-Durand (1613_CR200) 2020; 30 N Saeed (1613_CR113) 2017; 8 OY Addo (1613_CR52) 2010; 91 C Buttigliero (1613_CR155) 2015; 50 A Gursoy Coruh (1613_CR101) 2021; 76 RD Dolan (1613_CR80) 2019; 10 EJ Song (1613_CR68) 2018; 172 M Protani (1613_CR30) 2010; 123 ML Torres (1613_CR140) 2013; 129 W Gu (1613_CR205) 2015; 10 JJ Hopkins (1613_CR84) 2019; 62 MC Xu (1613_CR231) 2021; 205 M Mourtzakis (1613_CR48) 2008; 33 CS Lee (1613_CR87) 2020; 18 H Jayasekara (1613_CR251) 2018; 142 DP van Dijk (1613_CR228) 2017; 8 VP Grignol (1613_CR184) 2015; 24 T Iwase (1613_CR66) 2021; 13 EK Choi (1613_CR40) 2018; 29 Y Choi (1613_CR117) 2020; 42 K Ohwaki (1613_CR217) 2015; 51 G Ninomiya (1613_CR215) 2017; 39 MM Protani (1613_CR31) 2012; 5 X Huang (1613_CR138) 2020; 18 A Okamura (1613_CR106) 2018; 403 Y Zhang (1613_CR141) 2018; 28 H Donkers (1613_CR182) 2021; 256 M Papoulas (1613_CR191) 2015; 39 SS Shachar (1613_CR11) 2017; 26 T Perrin (1613_CR91) 2021; 17 K Katsui (1613_CR208) 2021; 11 MH Tao (1613_CR245) 2006; 163 TA Labeur (1613_CR125) 2019; 8 T Sasaki (1613_CR162) 2020; 25 A Goulart (1613_CR204) 2019; 36 Y Ryu (1613_CR148) 2020; 22 AB Cooper (1613_CR151) 2015; 22 BA Kuritzkes (1613_CR209) 2018; 33 Y Choi (1613_CR21) 2013; 132 ME Buechel (1613_CR202) 2021; 161 JC Nault (1613_CR126) 2015; 47 I Saeki (1613_CR127) 2019; 14 X Liu (1613_CR259) 2015; 21 H Lennon (1613_CR8) 2016; 18 D Ferrigno (1613_CR258) 2001; 9 JM Kocarnik (1613_CR276) 2016; 139 X-T Li (1613_CR105) 2015; 141 S Zhang (1613_CR248) 1995; 76 Y Takeoka (1613_CR194) 2016; 16 BJ Caan (1613_CR10) 2017; 26 J Stangl-Kremser (1613_CR163) 2020; 23 PE Abrahamson (1613_CR235) 2006; 15 JC Brown (1613_CR201) 2020; 112 A Silva (1613_CR224) 2021; 37 S Minami (1613_CR134) 2019; 10 BJ Caan (1613_CR12) 2018; 78 BJ Caan (1613_CR72) 2017; 26 S Okumura (1613_CR189) 2017; 24 MH Choi (1613_CR150) 2018; 9 PT Bradshaw (1613_CR69) 2019; 27 S Park (1613_CR260) 2014; 66 MC Gonzalez (1613_CR13) 2017; 20 J Yoon (1613_CR96) 2019; 29 JK Kays (1613_CR170) 2020; 12 A Kroh (1613_CR124) 2019; 18 KA Brown (1613_CR3) 2021; 17 V Fedirko (1613_CR249) 2014; 135 J Zhang (1613_CR36) 2018; 9 JW Lee (1613_CR210) 2019; 8 T Gadekar (1613_CR50) 2020; 76 D Schaffler-Schaden (1613_CR222) 2020; 405 J Wang (1613_CR34) 2018; 72 JW Lee (1613_CR115) 2019; 41 G Popinat (1613_CR136) 2019; 8 F Petrelli (1613_CR29) 2021; 4 MA Cornier (1613_CR275) 2011; 124 Y Cao (1613_CR19) 2011; 4 B Kim (1613_CR152) 2016; 68 W Xu (1613_CR46) 2021 LH Kim (1613_CR27) 2021; 205 G Malietzis (1613_CR88) 2016; 103 N Yamamoto (1613_CR232) 2012; 8 L Carcamo (1613_CR73) 2021; 91 JW Lee (1613_CR145) 2018; 73 X Bian (1613_CR199) 2018; 97 MJ Borugian (1613_CR236) 2003; 158 JP Higgins (1613_CR58) 2003; 327 BK De Amorim (1613_CR181) 2018; 59 M Elia (1613_CR42) 2013; 67 Y Naya (1613_CR174) 2010; 85 MK Ferguson (1613_CR131) 2020; 109 P Naumann (1613_CR146) 2019; 11 SS Zhang (1613_CR37) 2013; 109 A Chait (1613_CR263) 2020; 7 R Wochner (1613_CR149) 2020; 15 AR Jung (1613_CR114) 2019; 116 S Sheikhbahaei (1613_CR223) 2021; 81 E Deluche (1613_CR63) 2018; 26 X Sun (1613_CR244) 2015; 26 EK Choe (1613_CR76) 2016; 31 T Kobayashi (1613_CR123) 2018; 10 M Anjanappa (1613_CR262) 2020; 16 JS Han (1613_CR83) 2020; 52 AS Almasaudi (1613_CR70) 2020; 12 A Wisse (1613_CR246) 2018; 29 M Sugimoto (1613_CR225) 2018; 22 HY Jang (1613_CR122) 2021; 10 JR Gregg (1613_CR158) 2021; 205 J Gillen (1613_CR183) 2019; 30 S Looijaard (1613_CR211) 2020; 25 MJ Page (1613_CR17) 2021; 372 M Zhang (1613_CR247) 2017 AE Erbaycu (1613_CR257) 2010; 30 K Harada (1613_CR103) 2015; 22 T Iwase (1613_CR207) 2020; 179 ST McSorley (1613_CR89) 2018; 37 B Lauby-Secretan (1613_CR1) 2016; 375 JW Lee (1613_CR132) 2018; 50 DH Lee (1613_CR7) 2019; 8 A Gupta (1613_CR24) 2018; 41 Y Ha (1613_CR206) 2018; 50 AM Haydon (1613_CR250) 2006; 55 RL Siegel (1613_CR2) 2022; 72 RD Boutin (1613_CR178) 2020; 10 Y Hamaguchi (1613_CR119) 2019; 8 JS Park (1613_CR218) 2020; 12 Y Zhang (1613_CR110) 2021; 85 E Frostberg (1613_CR81) 2021; 62 KN Slaughter (1613_CR139) 2014; 133 |
References_xml | – volume: 76 start-page: 41 year: 2020 end-page: 46 ident: CR50 article-title: Correlation of visceral body fat with waist-hip ratio, waist circumference and body mass index in healthy adults: a cross sectional study publication-title: Med J Armed Forces India doi: 10.1016/j.mjafi.2017.12.001 – volume: 22 start-page: 2416 year: 2015 end-page: 2423 ident: CR151 article-title: Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-4285-2 – volume: 19 start-page: 122 year: 2016 end-page: 131 ident: CR39 article-title: Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis publication-title: Prostate Cancer Prostatic Dis doi: 10.1038/pcan.2015.64 – volume: 116 start-page: 98 year: 2019 end-page: 106 ident: CR114 article-title: Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer publication-title: Eur J Cancer doi: 10.1016/j.ejca.2019.05.006 – volume: 21 start-page: 283 year: 2020 end-page: 293 ident: CR266 article-title: Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study publication-title: Lancet Oncol doi: 10.1016/S1470-2045(19)30797-1 – volume: 40 start-page: 1817 year: 2016 end-page: 1822 ident: CR18 article-title: Renal cell carcinoma survival and body mass index: a dose-response meta-analysis reveals another potential paradox within a paradox publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2016.171 – volume: 46 start-page: 243 year: 2015 end-page: 250 ident: CR86 article-title: Visceral adiposity is a risk factor for poor prognosis in colorectal cancer patients receiving adjuvant chemotherapy publication-title: J Gastrointest Cancer doi: 10.1007/s12029-015-9709-0 – ident: CR16 – volume: 40 start-page: 286 year: 2021 end-page: 294 ident: CR71 article-title: Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: a pilot study publication-title: Clin Nutr doi: 10.1016/j.clnu.2020.05.019 – volume: 15 start-page: 1918 year: 2008 end-page: 1922 ident: CR213 article-title: Visceral obesity may affect oncologic outcome in patients with colorectal cancer publication-title: Ann Surg Oncol doi: 10.1245/s10434-008-9891-4 – ident: CR51 – volume: 10 start-page: e0122047 year: 2015 ident: CR164 article-title: Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review publication-title: PLoS ONE doi: 10.1371/journal.pone.0122047 – volume: 76 start-page: 275 year: 1995 end-page: 283 ident: CR248 article-title: Better breast cancer survival for postmenopausal women who are less overweight and eat less fat publication-title: Iowa Women's Health Study Cancer – volume: 50 start-page: 1088 year: 1994 end-page: 1101 ident: CR61 article-title: Operating characteristics of a rank correlation test for publication bias publication-title: Biometrics doi: 10.2307/2533446 – volume: 159 start-page: 103232 year: 2021 ident: CR274 article-title: The impact of anthropometric parameters on colorectal cancer prognosis: a systematic review and meta-analysis publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2021.103232 – volume: 23 start-page: 309 year: 2020 end-page: 315 ident: CR163 article-title: Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia publication-title: Prostate Cancer Prostatic Dis doi: 10.1038/s41391-019-0186-6 – volume: 129 start-page: 548 year: 2013 end-page: 553 ident: CR140 article-title: Nutritional status, CT body composition measures and survival in ovarian cancer publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2013.03.003 – volume: 11 start-page: 8201 year: 2019 end-page: 8207 ident: CR137 article-title: Correlation of body composition by computerized tomography and metabolic parameters with survival of nivolumab-treated lung cancer patients publication-title: Cancer Manage Res doi: 10.2147/CMAR.S210958 – volume: 25 start-page: 370 year: 2020 end-page: 376 ident: CR162 article-title: Pre-treatment ratio of periprostatic to subcutaneous fat thickness on MRI is an independent survival predictor in hormone-naïve men with advanced prostate cancer publication-title: Int J Clin Oncol doi: 10.1007/s10147-019-01559-y – volume: 12 start-page: e0169136 year: 2017 ident: CR214 article-title: Prognostic impact of CT-quantified muscle and fat distribution before and after first-line-chemotherapy in lung cancer patients publication-title: PLoS ONE doi: 10.1371/journal.pone.0169136 – volume: 3 start-page: 329 year: 2019 end-page: 337 ident: CR128 article-title: Skeletal muscle mass is associated with toxicity, treatment tolerability, and additional or subsequent therapies in patients with hepatocellular carcinoma receiving sorafenib treatment publication-title: JGH Open doi: 10.1002/jgh3.12167 – volume: 50 start-page: 308 year: 2018 end-page: 313 ident: CR132 article-title: Effect of adipose tissue volume on prognosis in patients with non-small cell lung cancer publication-title: Clin Imaging doi: 10.1016/j.clinimag.2018.05.006 – volume: 9 start-page: 326 year: 2018 end-page: 334 ident: CR150 article-title: Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12274 – volume: 39 start-page: 1895 year: 2015 end-page: 1901 ident: CR191 article-title: Visceral fat content correlates with retroperitoneal soft tissue sarcoma (STS) local recurrence and survival publication-title: World J Surg doi: 10.1007/s00268-015-3038-0 – volume: 123 start-page: 2188 year: 2008 end-page: 2194 ident: CR238 article-title: Effect of obesity and other lifestyle factors on mortality in women with breast cancer publication-title: Int J Cancer doi: 10.1002/ijc.23747 – volume: 102 start-page: 49 year: 2016 end-page: 59 ident: CR25 article-title: Premorbid body mass index and mortality in patients with lung cancer: a systematic review and meta-analysis publication-title: Lung Cancer doi: 10.1016/j.lungcan.2016.10.017 – volume: 39 start-page: 417 year: 2010 end-page: 420 ident: CR271 article-title: Illustrating bias due to conditioning on a collider publication-title: Int J Epidemiol doi: 10.1093/ije/dyp334 – volume: 12 start-page: 1605 year: 2020 ident: CR170 article-title: The combination of low skeletal muscle mass and high tumor interleukin-6 associates with decreased survival in clear cell renal cell carcinoma publication-title: Cancers doi: 10.3390/cancers12061605 – volume: 8 start-page: 1358 year: 2019 ident: CR210 article-title: Prognostic significance of abdominal-to-gluteofemoral adipose tissue distribution in patients with breast cancer publication-title: J Clin Med doi: 10.3390/jcm8091358 – volume: 11 start-page: 9 year: 2020 ident: CR135 article-title: Sarcopenia and visceral adiposity did not affect efficacy of immune-checkpoint inhibitor monotherapy for pretreated patients with advanced non-small cell lung cancer publication-title: World J Oncol doi: 10.14740/wjon1225 – volume: 97 start-page: e13878 year: 2018 ident: CR98 article-title: CT-quantified muscle and fat change in patients after surgery or endoscopic resection for early gastric cancer and its impact on long-term outcomes publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000013878 – volume: 26 start-page: 1008 year: 2017 end-page: 1015 ident: CR72 article-title: Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study) publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-17-0200 – volume: 19 start-page: 134 year: 2019 ident: CR75 article-title: Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials publication-title: BMC Cancer doi: 10.1186/s12885-019-5319-8 – volume: 37 start-page: 1279 year: 2018 end-page: 1285 ident: CR89 article-title: The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer publication-title: Clin Nutr doi: 10.1016/j.clnu.2017.05.017 – volume: 22 start-page: 3946 year: 2015 end-page: 3953 ident: CR103 article-title: Low visceral fat content is associated with poor prognosis in a database of 507 upper gastrointestinal cancers publication-title: Ann Surg Oncol doi: 10.1245/s10434-015-4432-4 – volume: 108 start-page: 104771 year: 2020 ident: CR185 article-title: Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancer publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2020.104771 – volume: 73 start-page: 1056 year: 2018 ident: CR145 article-title: Prognostic value of CT attenuation and FDG uptake of adipose tissue in patients with pancreatic adenocarcinoma publication-title: Clin Radiol doi: 10.1016/j.crad.2018.07.094 – volume: 256 start-page: 425 year: 2021 end-page: 432 ident: CR182 article-title: Obesity and visceral fat: survival impact in high-grade endometrial cancer publication-title: Eur J Obstet Gynecol Reprod Biol doi: 10.1016/j.ejogrb.2020.11.050 – volume: 192 start-page: 1043 year: 2014 end-page: 1049 ident: CR176 article-title: Visceral obesity in predicting oncologic outcomes of localized renal cell carcinoma publication-title: J Urol doi: 10.1016/j.juro.2014.03.107 – volume: 8 start-page: 255 year: 2019 end-page: 270 ident: CR125 article-title: Body composition is an independent predictor of outcome in patients with hepatocellular carcinoma treated with sorafenib publication-title: Liver cancer doi: 10.1159/000493586 – volume: 25 start-page: 1388 year: 2021 end-page: 1403 ident: CR220 article-title: Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population publication-title: J Gastrointest Surg doi: 10.1007/s11605-020-04716-1 – volume: 51 start-page: 2570 year: 2015 end-page: 2577 ident: CR154 article-title: High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting publication-title: Eur J Cancer doi: 10.1016/j.ejca.2015.07.042 – year: 2017 ident: CR247 article-title: Body mass index, waist-to-hip ratio and late outcomes: a report from the Shanghai Breast Cancer Survival Study publication-title: Sci Rep doi: 10.1038/s41598-017-07320-7 – volume: 12 start-page: 346 year: 2014 end-page: 352 ident: CR104 article-title: Impact of intra-abdominal fat on surgical outcome and overall survival of patients with gastric cancer publication-title: Int J Surg doi: 10.1016/j.ijsu.2014.01.010 – volume: 333 start-page: 1109 year: 2006 end-page: 1111 ident: CR6 article-title: ABC of obesity publication-title: Obes Cancer BMJ – volume: 25 start-page: 1901 year: 2014 end-page: 1914 ident: CR20 article-title: Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies publication-title: Ann Oncol doi: 10.1093/annonc/mdu042 – volume: 11 start-page: 534 year: 2020 end-page: 546 ident: CR142 article-title: Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12524 – volume: 30 start-page: 100502 year: 2019 ident: CR183 article-title: Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab publication-title: Gynecol Oncol Rep doi: 10.1016/j.gore.2019.100502 – volume: 4 start-page: e213520 year: 2021 ident: CR29 article-title: Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.3520 – volume: 51 start-page: 604 year: 2015 end-page: 609 ident: CR217 article-title: Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy publication-title: Eur J Cancer doi: 10.1016/j.ejca.2015.01.003 – volume: 41 start-page: 874 year: 2018 ident: CR24 article-title: Obesity is independently associated with increased risk of hepatocellular cancer-related mortality: a systematic review and meta-analysis publication-title: Am J Clin Oncol doi: 10.1097/COC.0000000000000388 – volume: 141 start-page: 1237 year: 2015 end-page: 1247 ident: CR105 article-title: Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-adjuvant chemotherapy publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-014-1893-y – volume: 19 start-page: 2908 year: 2012 end-page: 2916 ident: CR143 article-title: Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma publication-title: Ann Surg Oncol doi: 10.1245/s10434-012-2301-y – volume: 50 start-page: 843 year: 2018 end-page: 851 ident: CR206 article-title: Sarcopenia predicts prognosis in patients with newly diagnosed hepatocellular carcinoma, independent of tumor stage and liver function publication-title: Cancer Res Treat doi: 10.4143/crt.2017.232 – volume: 142 start-page: 238 year: 2018 end-page: 250 ident: CR251 article-title: Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype publication-title: Int J Cancer doi: 10.1002/ijc.31049 – volume: 13 start-page: 608 year: 2021 ident: CR66 article-title: The prognostic impact of body composition for locally advanced breast cancer patients who received neoadjuvant chemotherapy publication-title: Cancers (Basel) doi: 10.3390/cancers13040608 – volume: 10 start-page: 2231 year: 2018 end-page: 2239 ident: CR123 article-title: Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy publication-title: Cancer Manag Res doi: 10.2147/CMAR.S167417 – volume: 43 start-page: 2052 year: 2018 end-page: 2059 ident: CR234 article-title: Usefulness of metabolic activity of adipose tissue in FDG PET/CT of colorectal cancer publication-title: Abdom Radiol doi: 10.1007/s00261-017-1418-7 – volume: 31 start-page: 2472 year: 2021 end-page: 2481 ident: CR153 article-title: Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy publication-title: Eur Radiol doi: 10.1007/s00330-020-07294-7 – volume: 26 start-page: 1365 year: 2015 end-page: 1373 ident: CR23 article-title: Impact of pre-diagnosis behavior on risk of death from esophageal cancer: a systematic review and meta-analysis publication-title: Cancer Causes Control doi: 10.1007/s10552-015-0635-z – volume: 76 start-page: 228 year: 2021 end-page: 234 ident: CR101 article-title: Prognostic implications of visceral obesity on gastric adenocarcinoma: does it really matter? publication-title: Clin Imaging doi: 10.1016/j.clinimag.2021.03.035 – volume: 80 start-page: 1244 year: 2020 end-page: 1252 ident: CR157 article-title: Abdominal and pelvic adipose tissue distribution and risk of prostate cancer recurrence after radiation therapy publication-title: Prostate doi: 10.1002/pros.24054 – volume: 94 start-page: e1269 year: 2015 ident: CR32 article-title: The association between body mass index and the prognosis and postoperative complications of hepatocellular carcinoma: a meta-analysis publication-title: Medicine doi: 10.1097/MD.0000000000001269 – volume: 193 start-page: 1507 year: 2015 end-page: 1513 ident: CR192 article-title: Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting publication-title: J Urol doi: 10.1016/j.juro.2014.11.088 – volume: 38 start-page: 491 year: 2018 end-page: 499 ident: CR90 article-title: Low visceral fat content is a negative predictive marker for bevacizumab in metastatic colorectal cancer publication-title: Anticancer Res – volume: 25 start-page: 3222 year: 2018 end-page: 3230 ident: CR107 article-title: Marked loss of muscle, visceral fat, or subcutaneous fat after gastrectomy predicts poor survival in advanced gastric cancer: single-center study from the CLASSIC Trial publication-title: Ann Surg Oncol doi: 10.1245/s10434-018-6624-1 – volume: 42 start-page: 2614 year: 2020 end-page: 2625 ident: CR117 article-title: Prognostic value of computed tomography-based volumetric body composition analysis in patients with head and neck cancer: feasibility study publication-title: Head Neck doi: 10.1002/hed.26310 – volume: 10 start-page: 854 year: 2021 end-page: 866 ident: CR122 article-title: Sarcopenia and visceral adiposity predict poor overall survival in hepatocellular carcinoma patients after curative hepatic resection publication-title: Transl Cancer Res doi: 10.21037/tcr-20-2974 – volume: 181 start-page: 199 year: 2020 end-page: 209 ident: CR64 article-title: Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-020-05617-2 – volume: 11 start-page: 679158 year: 2021 ident: CR190 article-title: Body composition parameters may be prognostic factors in upper urinary tract urothelial carcinoma treated by radical nephroureterectomy publication-title: Front Oncol doi: 10.3389/fonc.2021.679158 – volume: 9 start-page: 13959 year: 2018 end-page: 13970 ident: CR36 article-title: Association of body mass index with mortality and postoperative survival in renal cell cancer patients, a meta-analysis publication-title: Oncotarget doi: 10.18632/oncotarget.24210 – volume: 41 start-page: 1605 year: 2019 end-page: 1614 ident: CR115 article-title: Visceral adipose tissue volume and CT-attenuation as prognostic factors in patients with head and neck cancer publication-title: Head Neck doi: 10.1002/hed.25605 – volume: 109 start-page: 873 year: 2020 end-page: 878 ident: CR131 article-title: A morphomic index is an independent predictor of survival after lung cancer resection publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2019.10.064 – volume: 33 start-page: 997 year: 2008 end-page: 1006 ident: CR48 article-title: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care publication-title: Appl Physiol Nutr Metab doi: 10.1139/H08-075 – volume: 19 start-page: 644 year: 2019 ident: CR74 article-title: Impact of genetic mutations and nutritional status on the survival of patients with colorectal cancer publication-title: BMC Cancer doi: 10.1186/s12885-019-5837-4 – volume: 5 start-page: 1 year: 2016 end-page: 8 ident: CR237 article-title: Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women publication-title: Springerplus doi: 10.1186/s40064-015-1659-2 – volume: 13 start-page: 404 year: 2011 end-page: 410 ident: CR261 article-title: Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinoma publication-title: HPB (Oxford) doi: 10.1111/j.1477-2574.2011.00304.x – volume: 50 start-page: 223 year: 2015 end-page: 230 ident: CR155 article-title: The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome publication-title: Endocrine doi: 10.1007/s12020-015-0525-x – volume: 5 start-page: 901 year: 2012 end-page: 910 ident: CR31 article-title: Obesity and ovarian cancer survival: a systematic review and meta-analysis publication-title: Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-12-0048 – volume: 12 start-page: 1986 year: 2020 ident: CR70 article-title: Hypoalbuminemia reflects nutritional risk, body composition and systemic inflammation and is independently associated with survival in patients with colorectal cancer publication-title: Cancers (Basel) doi: 10.3390/cancers12071986 – volume: 11 start-page: 135 year: 2020 end-page: 144 ident: CR112 article-title: Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12484 – volume: 12 start-page: E331 year: 2018 end-page: E337 ident: CR160 article-title: Examining the association between adiposity and biochemical recurrence after radical prostatectomy publication-title: Can Urol Assoc J doi: 10.5489/cuaj.4923 – volume: 30 start-page: 3528 year: 2020 end-page: 3537 ident: CR200 article-title: Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer publication-title: Eur Radiol doi: 10.1007/s00330-019-06630-w – year: 2021 ident: CR46 article-title: Fatty acid synthase correlates with prognosis-related abdominal adipose distribution and metabolic disorders of clear cell renal cell carcinoma publication-title: Front Mol Biosci doi: 10.3389/fmolb.2020.610229 – volume: 9 start-page: 629 year: 2008 end-page: 635 ident: CR47 article-title: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study publication-title: Lancet Oncol doi: 10.1016/S1470-2045(08)70153-0 – volume: 105 start-page: 365 year: 2012 end-page: 370 ident: CR198 article-title: Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma publication-title: J Surg Oncol doi: 10.1002/jso.22031 – volume: 91 start-page: E298 year: 2021 end-page: E306 ident: CR73 article-title: Computed tomography-measured body composition parameters do not influence survival in non-metastatic colorectal cancer publication-title: ANZ J Surg doi: 10.1111/ans.16708 – volume: 12 start-page: 891 year: 2020 end-page: 903 ident: CR167 article-title: The prognostic value of body fat components in metastasis renal cell carcinoma patients treated with TKIs publication-title: Cancer Manage Res doi: 10.2147/CMAR.S230973 – volume: 18 start-page: 56 year: 2016 ident: CR8 article-title: The obesity paradox in cancer: a review publication-title: Curr Oncol Rep doi: 10.1007/s11912-016-0539-4 – volume: 81 start-page: 477 year: 2018 end-page: 483 ident: CR197 article-title: Comparison between abdominal fat measured by CT and anthropometric indices as prediction factors for mortality and morbidity after colorectal surgery publication-title: Acta Gastro-Enterol Belg – volume: 22 start-page: 1697 year: 2018 end-page: 1708 ident: CR180 article-title: Pre-operative sarcopenia identifies patients at risk for poor survival after resection of biliary tract cancers publication-title: J Gastrointest Surg doi: 10.1007/s11605-018-3802-1 – volume: 36 start-page: 33 year: 2019 end-page: 40 ident: CR204 article-title: Influence of visceral fat in the outcomes of colorectal cancer publication-title: Dig Surg doi: 10.1159/000486143 – volume: 27 start-page: 205 year: 1977 end-page: 208 ident: CR269 article-title: Weight loss in cancer patients publication-title: CA Cancer J Clin doi: 10.3322/canjclin.27.4.205 – volume: 26 start-page: 17 year: 2017 end-page: 20 ident: CR272 article-title: The obesity paradox in survival after cancer diagnosis: tools for evaluation of potential bias publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-16-0559 – volume: 22 start-page: 1782 year: 2020 end-page: 1792 ident: CR148 article-title: The effects of sarcopenia and sarcopenic obesity after pancreaticoduodenectomy in patients with pancreatic head cancer publication-title: HPB doi: 10.1016/j.hpb.2020.04.004 – volume: 205 start-page: 122 year: 2021 end-page: 128 ident: CR158 article-title: The association of periprostatic fat and grade group progression in men with localized prostate cancer on active surveillance publication-title: J Urol doi: 10.1097/JU.0000000000001321 – volume: 8 start-page: 175 year: 2019 end-page: 181 ident: CR7 article-title: The obesity paradox in cancer: epidemiologic insights and perspectives publication-title: Curr Nutr Rep doi: 10.1007/s13668-019-00280-6 – volume: 22 start-page: 62 year: 2020 end-page: 70 ident: CR94 article-title: The clinical impact of preoperative body composition differs between male and female colorectal cancer patients publication-title: Colorectal Dis doi: 10.1111/codi.14793 – volume: 8 start-page: 317 year: 2017 end-page: 326 ident: CR228 article-title: Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12155 – volume: 10 start-page: 1580 year: 2020 end-page: 1589 ident: CR178 article-title: Association of adipose tissue and skeletal muscle metrics with overall survival and postoperative complications in soft tissue sarcoma patients: an opportunistic study using computed tomography publication-title: Quant Imaging Med Surg doi: 10.21037/qims.2020.02.09 – volume: 17 start-page: 575 year: 2021 end-page: 584 ident: CR91 article-title: Effects of body composition profiles on oncological outcomes and postoperative intraabdominal infection following colorectal cancer surgery publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2020.10.022 – volume: 11 start-page: 139 year: 2020 ident: CR133 article-title: Sarcopenia and visceral adiposity are not independent prognostic markers for extensive disease of small-cell lung cancer: a single-centered retrospective cohort study publication-title: World J Oncol doi: 10.14740/wjon1289 – volume: 20 start-page: 314 year: 2017 end-page: 321 ident: CR13 article-title: A requiem for BMI in the clinical setting publication-title: Curr Opin Clin Nutr Metab Care doi: 10.1097/MCO.0000000000000395 – volume: 161 start-page: 382 year: 2021 end-page: 388 ident: CR202 article-title: Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC) publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2021.02.032 – volume: 8 start-page: 337 year: 2012 end-page: 345 ident: CR232 article-title: Impact of body mass index and visceral adiposity on outcomes in colorectal cancer publication-title: Asia Pac J Clin Oncol doi: 10.1111/j.1743-7563.2011.01512.x – volume: 24 start-page: 1037 year: 2017 end-page: 1045 ident: CR189 article-title: Impact of skeletal muscle mass, muscle quality, and visceral adiposity on outcomes following resection of intrahepatic cholangiocarcinoma publication-title: Ann Surg Oncol doi: 10.1245/s10434-016-5668-3 – volume: 132 start-page: 625 year: 2013 end-page: 634 ident: CR21 article-title: Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis publication-title: Int J Cancer doi: 10.1002/ijc.27639 – volume: 59 start-page: 341 year: 2010 end-page: 347 ident: CR82 article-title: Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer publication-title: Gut doi: 10.1136/gut.2009.188946 – volume: 25 start-page: 1489 year: 2014 end-page: 1502 ident: CR35 article-title: Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies publication-title: Cancer Causes Control doi: 10.1007/s10552-014-0450-y – volume: 95 start-page: e3305 year: 2016 ident: CR33 article-title: Effect of body mass index on overall survival of pancreatic cancer: a meta-analysis publication-title: Medicine doi: 10.1097/MD.0000000000003305 – volume: 72 start-page: 7 year: 2022 end-page: 33 ident: CR2 article-title: Cancer statistics, 2022 publication-title: CA Cancer J Clin doi: 10.3322/caac.21708 – volume: 8 start-page: 833 year: 2017 end-page: 841 ident: CR113 article-title: CT-based assessment of visceral adiposity and outcomes for esophageal adenocarcinoma publication-title: J Gastrointest Oncol doi: 10.21037/jgo.2017.07.03 – volume: 27 start-page: e12611 year: 2018 ident: CR267 article-title: Visceral adiposity and cancer survival: a review of imaging studies publication-title: Eur J Cancer Care doi: 10.1111/ecc.12611 – volume: 13 start-page: e39 year: 2016 end-page: e45 ident: CR156 article-title: Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel publication-title: Clin Nutr ESPEN doi: 10.1016/j.clnesp.2016.04.001 – volume: 14 start-page: 1832 year: 2010 end-page: 1837 ident: CR45 article-title: Intra-abdominal fat predicts survival in pancreatic cancer publication-title: J Gastrointest Surg doi: 10.1007/s11605-010-1297-5 – volume: 291 start-page: 547 year: 2019 end-page: 552 ident: CR14 article-title: Clinical imaging research: higher evidence, global collaboration, improved reporting, and data sharing are the grand challenges publication-title: Radiology doi: 10.1148/radiol.2019181796 – volume: 6 start-page: 5280 year: 2014 end-page: 5297 ident: CR270 article-title: Evidence and mechanisms of fat depletion in cancer publication-title: Nutrients doi: 10.3390/nu6115280 – volume: 12 start-page: 60 year: 2019 ident: CR78 article-title: Changes in body composition during adjuvant FOLFOX chemotherapy and overall survival in non-metastatic colon cancer publication-title: Cancers (Basel) doi: 10.3390/cancers12010060 – ident: CR277 – volume: 105 start-page: 1862 year: 2013 end-page: 1870 ident: CR265 article-title: An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djt310 – ident: CR43 – volume: 91 start-page: 635 year: 2010 end-page: 642 ident: CR52 article-title: Reference curves for triceps and subscapular skinfold thicknesses in US children and adolescents publication-title: Am J Clin Nutr doi: 10.3945/ajcn.2009.28385 – volume: 12 start-page: 1063 year: 2011 end-page: 1070 ident: CR4 article-title: Multiple signal pathways in obesity-associated cancer publication-title: Obes Rev doi: 10.1111/j.1467-789X.2011.00917.x – volume: 16 start-page: 71 year: 2011 end-page: 81 ident: CR171 article-title: Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents publication-title: Oncologist doi: 10.1634/theoncologist.2010-0227 – volume: 16 start-page: 1565 year: 2011 end-page: 1571 ident: CR177 article-title: Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy? publication-title: Oncologist doi: 10.1634/theoncologist.2011-0213 – volume: 139 start-page: 1053 year: 2016 end-page: 1064 ident: CR241 article-title: Prediagnostic body size and breast cancer survival in the E3N cohort study publication-title: Int J Cancer doi: 10.1002/ijc.30158 – volume: 403 start-page: 245 year: 2018 end-page: 253 ident: CR106 article-title: Implication of visceral obesity in patients with esophageal squamous cell carcinoma publication-title: Langenbecks Arch Surg doi: 10.1007/s00423-018-1722-x – volume: 11 start-page: 11882 year: 2021 ident: CR208 article-title: Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis publication-title: Sci Rep doi: 10.1038/s41598-021-91449-z – volume: 58 start-page: 839 year: 2009 end-page: 844 ident: CR216 article-title: Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH publication-title: Gut doi: 10.1136/gut.2008.164053 – volume: 2021 start-page: 6657566 year: 2021 ident: CR233 article-title: Association between CT-quantified body composition and recurrence, survival in nonmetastasis colorectal cancer patients underwent regular chemotherapy after surgery publication-title: Biomed Res Int – year: 2017 ident: CR173 article-title: Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy publication-title: Med Oncol doi: 10.1007/s12032-017-0908-3 – volume: 15 start-page: e0242785 year: 2020 ident: CR149 article-title: Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients publication-title: PLoS ONE doi: 10.1371/journal.pone.0242785 – volume: 14 start-page: e0218136 year: 2019 ident: CR127 article-title: Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparison with sorafenib therapy publication-title: PLoS ONE doi: 10.1371/journal.pone.0218136 – volume: 72 start-page: 436 year: 2018 end-page: 445 ident: CR109 article-title: Impact of visceral fat on surgical complications and long-term survival of patients with gastric cancer after radical gastrectomy publication-title: Eur J Clin Nutr doi: 10.1038/s41430-017-0032-7 – volume: 78 start-page: 1906 year: 2018 end-page: 1912 ident: CR12 article-title: The importance of body composition in explaining the overweight paradox in cancer-counterpoint publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-3287 – volume: 11 start-page: 10628 year: 2021 ident: CR44 article-title: Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC publication-title: Sci Rep doi: 10.1038/s41598-021-90187-6 – volume: 205 start-page: 346 year: 2021 end-page: 355 ident: CR27 article-title: A systematic review and meta-analysis of the significance of Body Mass Index on kidney cancer outcomes publication-title: J Urol doi: 10.1097/JU.0000000000001377 – volume: 15 start-page: e0238649 year: 2020 ident: CR144 article-title: Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer publication-title: PLoS ONE doi: 10.1371/journal.pone.0238649 – volume: 15 start-page: 1871 year: 2006 end-page: 1877 ident: CR235 article-title: General and abdominal obesity and survival among young women with breast cancer publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-06-0356 – volume: 28 start-page: 285 year: 2018 end-page: 292 ident: CR141 article-title: Perirenal adiposity is associated with lower progression-free survival from ovarian cancer publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0000000000001165 – volume: 112 start-page: 377 year: 2020 end-page: 383 ident: CR201 article-title: The association of abdominal adiposity with mortality in patients with stage I-III colorectal cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djz150 – volume: 124 start-page: 1996 year: 2011 end-page: 2019 ident: CR275 article-title: Assessing adiposity: a scientific statement from the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0b013e318233bc6a – volume: 103 start-page: 572 year: 2016 end-page: 580 ident: CR88 article-title: Influence of body composition profile on outcomes following colorectal cancer surgery publication-title: Br J Surg doi: 10.1002/bjs.10075 – volume: 9 start-page: 53 year: 2018 end-page: 59 ident: CR77 article-title: Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12234 – volume: 22 start-page: 1164 year: 1998 end-page: 1171 ident: CR9 article-title: Body mass index and percent body fat: a meta analysis among different ethnic groups publication-title: Int J Obes Relat Metab Disord doi: 10.1038/sj.ijo.0800741 – volume: 26 start-page: 981 year: 2017 ident: CR11 article-title: The obesity paradox in cancer-moving beyond BMI-response publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-17-0144 – volume: 25 start-page: 165 year: 1971 ident: CR53 article-title: Measurement of triceps skinfold thickness. An investigation of sources of variation publication-title: Br J Prev Soc Med – volume: 96 start-page: 328 year: 2015 end-page: 338 ident: CR26 article-title: Pretreatment body mass index and head and neck cancer outcome: a review of the literature publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2015.06.002 – volume: 97 start-page: 2333 year: 1985 end-page: 2338 ident: CR15 article-title: (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image publication-title: J Appl Physiol doi: 10.1152/japplphysiol.00744.2004 – volume: 109 start-page: 2894 year: 2013 end-page: 2903 ident: CR37 article-title: The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis publication-title: Br J Cancer doi: 10.1038/bjc.2013.666 – volume: 63 start-page: 131 year: 2015 end-page: 140 ident: CR118 article-title: Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma publication-title: J Hepatol doi: 10.1016/j.jhep.2015.02.031 – volume: 119 start-page: 3377 year: 2013 end-page: 3384 ident: CR166 article-title: Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies publication-title: Cancer doi: 10.1002/cncr.28218 – volume: 10 start-page: 123 year: 2019 end-page: 130 ident: CR229 article-title: Host phenotype is associated with reduced survival independent of tumour biology in patients with colorectal liver metastases publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12358 – ident: CR59 – volume: 9 start-page: 14058 year: 2018 end-page: 14067 ident: CR130 article-title: Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment publication-title: Oncotarget doi: 10.18632/oncotarget.24500 – volume: 85 start-page: 111135 year: 2021 ident: CR110 article-title: Impact of body composition on clinical outcomes in people with gastric cancer undergoing radical gastrectomy after neoadjuvant treatment publication-title: Nutrition doi: 10.1016/j.nut.2020.111135 – volume: 19 start-page: 6074 year: 2013 end-page: 6083 ident: CR5 article-title: Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-2603 – volume: 16 start-page: 434 year: 2016 end-page: 441 ident: CR194 article-title: Prognostic effect of low subcutaneous adipose tissue on survival outcome in patients with multiple myeloma publication-title: Clin Lymphoma Myeloma Leuk doi: 10.1016/j.clml.2016.04.010 – volume: 179 start-page: 95 year: 2014 end-page: 111 ident: CR242 article-title: Obesity and mortality after breast cancer by race/ethnicity: the California breast cancer survivorship consortium publication-title: Am J Epidemiol doi: 10.1093/aje/kwt233 – volume: 216 start-page: 1070 year: 2013 end-page: 1081 ident: CR79 article-title: Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2013.01.007 – volume: 27 start-page: 997 year: 2019 end-page: 1004 ident: CR69 article-title: Adipose tissue distribution and survival among women with nonmetastatic breast cancer publication-title: Obesity doi: 10.1002/oby.22458 – volume: 22 start-page: 703 year: 2018 end-page: 712 ident: CR203 article-title: Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and pancreatoduodenectomy publication-title: J Gastrointest Surg doi: 10.1007/s11605-017-3618-4 – volume: 26 start-page: 1359 year: 2016 end-page: 1367 ident: CR226 article-title: Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer publication-title: Eur Radiol doi: 10.1007/s00330-015-3963-1 – volume: 17 start-page: 133 year: 2013 end-page: 43 ident: CR92 article-title: Visceral obesity and colorectal cancer: are we missing the boat with BMI? publication-title: J Gastrointest Surg doi: 10.1007/s11605-012-2045-9 – volume: 22 start-page: 831 year: 2018 end-page: 839 ident: CR225 article-title: Decreased skeletal muscle volume is a predictive factor for poorer survival in patients undergoing surgical resection for pancreatic ductal adenocarcinoma publication-title: J Gastrointest Surg doi: 10.1007/s11605-018-3695-z – volume: 140 start-page: 292 year: 2017 end-page: 301 ident: CR253 article-title: Prediagnosis body mass index and waist–hip circumference ratio in association with colorectal cancer survival publication-title: Int J Cancer doi: 10.1002/ijc.30459 – volume: 26 start-page: 861 year: 2018 end-page: 868 ident: CR63 article-title: Impact of body composition on outcome in patients with early breast cancer publication-title: Support Care Cancer doi: 10.1007/s00520-017-3902-6 – ident: CR54 – volume: 24 start-page: 998 year: 2014 end-page: 1005 ident: CR49 article-title: Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer publication-title: Eur Radiol doi: 10.1007/s00330-014-3110-4 – volume: 33 start-page: 1019 year: 2018 end-page: 1028 ident: CR209 article-title: Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancer publication-title: Int J Colorectal Dis doi: 10.1007/s00384-018-3038-2 – volume: 64 start-page: 449S year: 1996 end-page: S452 ident: CR41 article-title: Limitations of the bioelectrical impedance method for the assessment of body fat in severe obesity publication-title: Am J Clin Nutr doi: 10.1093/ajcn/64.3.449S – volume: 30 start-page: 1177 year: 2010 end-page: 1184 ident: CR257 article-title: Initial anthropometric values and nutritional status is related to survival in advanced non-small cell lung cancer publication-title: Turk Klin J Med Sci – volume: 287 start-page: 884 year: 2018 end-page: 892 ident: CR175 article-title: Synergy of sex differences in visceral fat measured with CT and tumor metabolism helps predict overall survival in patients with renal cell carcinoma publication-title: Radiology doi: 10.1148/radiol.2018171504 – volume: 179 start-page: 435 year: 2020 end-page: 443 ident: CR207 article-title: Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancer publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-019-05467-7 – volume: 405 start-page: 469 year: 2020 end-page: 477 ident: CR222 article-title: Skeletal muscle index is an independent predictor of early recurrence in non-obese colon cancer patients publication-title: Langenbecks Arch Surg doi: 10.1007/s00423-020-01901-3 – volume: 45 start-page: 210 year: 2015 end-page: 216 ident: CR169 article-title: Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma publication-title: Jpn J Clin Oncol doi: 10.1093/jjco/hyu193 – volume: 16 start-page: 50 year: 2020 end-page: 57 ident: CR262 article-title: Sarcopenia in cancer: risking more than muscle loss publication-title: Tech Innov Patient Support Radiat Oncol doi: 10.1016/j.tipsro.2020.10.001 – volume: 29 start-page: 956 year: 2020 end-page: 965 ident: CR227 article-title: Associations of abdominal skeletal muscle mass, fat mass, and mortality among men and women with stage I-III colorectal cancer publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-19-1134 – volume: 31 start-page: 1571 year: 2016 end-page: 1578 ident: CR76 article-title: Prognostic impact of changes in adipose tissue areas after colectomy in colorectal cancer patients publication-title: J Korean Med Sci doi: 10.3346/jkms.2016.31.10.1571 – volume: 67 start-page: S60 issue: Suppl 1 year: 2013 end-page: 70 ident: CR42 article-title: Body composition by whole-body bioelectrical impedance and prediction of clinically relevant outcomes: overvalued or underused? publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2012.166 – volume: 5 start-page: 41 year: 2016 end-page: 48 ident: CR67 article-title: Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients publication-title: Cancer Med doi: 10.1002/cam4.571 – year: 2015 ident: CR57 publication-title: Meta-analysis with R doi: 10.1007/978-3-319-21416-0 – volume: 62 start-page: 182 year: 2021 end-page: 189 ident: CR81 article-title: Three different computed tomography obesity indices, two standard methods, and one novel measurement, and their association with outcomes after colorectal cancer surgery publication-title: Acta Radiol doi: 10.1177/0284185120918373 – volume: 7 start-page: 261 year: 2018 end-page: 272 ident: CR264 article-title: Subcutaneous adipose tissue accumulation protects systemic glucose tolerance and muscle metabolism publication-title: Adipocyte doi: 10.1080/21623945.2018.1525252 – volume: 139 start-page: 1065 year: 2016 end-page: 1072 ident: CR276 article-title: Relationship of prediagnostic body mass index with survival after colorectal cancer: stage-specific associations publication-title: Int J Cancer doi: 10.1002/ijc.30163 – volume: 30 start-page: 114 year: 2021 end-page: 122 ident: CR111 article-title: Low subcutaneous adiposity and mortality in esophageal cancer publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-20-0737 – volume: 19 start-page: 2229 year: 2010 end-page: 2237 ident: CR252 article-title: Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women's Health Study publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-10-0522 – volume: 36 start-page: 1509 year: 2012 end-page: 1516 ident: CR188 article-title: Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma publication-title: World J Surg doi: 10.1007/s00268-012-1581-5 – year: 2020 ident: CR161 article-title: Association of body composition with survival and treatment efficacy in castration-resistant prostate cancer publication-title: Front Oncol doi: 10.3389/fonc.2020.00558 – volume: 8 start-page: 105184 year: 2017 end-page: 105195 ident: CR187 article-title: High visceral fat percentage is associated with poor outcome in endometrial cancer publication-title: Oncotarget doi: 10.18632/oncotarget.21917 – volume: 10 start-page: 1079 year: 2021 ident: CR97 article-title: Role of baseline computed-tomography-evaluated body composition in predicting outcome and toxicity from first-line therapy in advanced gastric cancer patients publication-title: J Clin Med doi: 10.3390/jcm10051079 – volume: 108 start-page: 169 year: 2013 end-page: 175 ident: CR221 article-title: Analytic morphometric assessment of patients undergoing colectomy for colon cancer publication-title: J Surg Oncol doi: 10.1002/jso.23366 – volume: 59 start-page: 799 year: 2020 end-page: 808 ident: CR93 article-title: Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease publication-title: Acta Oncol doi: 10.1080/0284186X.2020.1744716 – volume: 8 start-page: e000821 year: 2020 ident: CR195 article-title: Impact of body composition on outcomes from anti-PD1 +/-anti-CTLA-4 treatment in melanoma publication-title: J Immunotherapy Cancer doi: 10.1136/jitc-2020-000821 – volume: 9 start-page: 522 year: 2001 end-page: 527 ident: CR258 article-title: Anthropometric measurements in non-small-cell lung cancer publication-title: Support Care Cancer doi: 10.1007/s005200100268 – ident: CR278 – volume: 52 start-page: 563 year: 2020 end-page: 572 ident: CR83 article-title: Association of body composition with long-term survival in non-metastatic rectal cancer patients publication-title: Cancer Res Treat doi: 10.4143/crt.2019.249 – volume: 95 start-page: 409 year: 2016 end-page: 416 ident: CR193 article-title: Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP publication-title: Ann Hematol doi: 10.1007/s00277-015-2571-0 – volume: 97 start-page: e10988 year: 2018 ident: CR199 article-title: Prognostic values of abdominal body compositions on survival in advanced pancreatic cancer publication-title: Medicine doi: 10.1097/MD.0000000000010988 – volume: 4 start-page: 486 year: 2011 end-page: 501 ident: CR19 article-title: Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis publication-title: Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-10-0229 – volume: 44 start-page: 1971 year: 2018 end-page: 1981 ident: CR38 article-title: Does high body mass index negatively affect the surgical outcome and long-term survival of gastric cancer patients who underwent gastrectomy: a systematic review and meta-analysis publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2018.09.007 – volume: 19 start-page: 1513 year: 2015 end-page: 1521 ident: CR219 article-title: Visceral obesity predicts fewer lymph node metastases and better overall survival in colon cancer publication-title: J Gastrointest Surg doi: 10.1007/s11605-015-2834-z – volume: 40 start-page: 3360 year: 2021 end-page: 3369 ident: CR99 article-title: Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: a comprehensive analysis from a large-scale prospective study publication-title: Clin Nutr doi: 10.1016/j.clnu.2020.11.007 – volume: 10 start-page: e0118022 year: 2015 ident: CR205 article-title: Prognostic value of components of body composition in patients treated with targeted therapy for advanced renal cell carcinoma: a retrospective case series publication-title: PLoS ONE doi: 10.1371/journal.pone.0118022 – volume: 27 start-page: 525 year: 2016 ident: CR273 article-title: Collider bias is only a partial explanation for the obesity paradox publication-title: Epidemiology doi: 10.1097/EDE.0000000000000493 – volume: 47 start-page: 869 year: 2015 end-page: 876 ident: CR126 article-title: Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors publication-title: Dig Liver Dis doi: 10.1016/j.dld.2015.07.001 – volume: 18 start-page: 230 year: 2020 ident: CR87 article-title: Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study publication-title: World J Surg Oncol doi: 10.1186/s12957-020-02006-3 – volume: 23 start-page: 80 year: 2020 end-page: 92 ident: CR65 article-title: Prognostic value of skeletal muscle depletion measured on computed tomography for overall survival in patients with non-metastatic breast cancer publication-title: J Breast Cancer doi: 10.4048/jbc.2020.23.e8 – volume: 55 start-page: 62 year: 2006 end-page: 67 ident: CR250 article-title: Effect of physical activity and body size on survival after diagnosis with colorectal cancer publication-title: Gut doi: 10.1136/gut.2005.068189 – volume: 37 start-page: 101606 year: 2021 ident: CR224 article-title: Visceral obesity is associated with lower stage colon tumors in males without survival advantage publication-title: Surg Oncol doi: 10.1016/j.suronc.2021.101606 – volume: 72 start-page: 4 year: 2018 end-page: 17 ident: CR34 article-title: Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2017.70 – volume: 327 start-page: 557 year: 2003 end-page: 560 ident: CR58 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ doi: 10.1136/bmj.327.7414.557 – volume: 85 start-page: 30 year: 2010 end-page: 36 ident: CR174 article-title: Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma publication-title: Urol Int doi: 10.1159/000318988 – volume: 35 start-page: 215 year: 2010 end-page: 247 ident: CR55 article-title: How many studies do you need? A primer on statistical power for meta-analysis publication-title: J Educ Behav Stat doi: 10.3102/1076998609346961 – volume: 26 start-page: 173 year: 2016 end-page: 178 ident: CR165 article-title: Impact of visceral fat volume and fat density on biochemical outcome after radical prostatectomy and postoperative radiotherapy publication-title: Horm Mol Biol Clin Investig – volume: 18 start-page: 1 year: 2020 end-page: 10 ident: CR138 article-title: Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trial publication-title: BMC Med doi: 10.1186/s12916-019-1443-1 – volume: 7 start-page: 22 year: 2020 ident: CR263 article-title: Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2020.00022 – volume: 24 start-page: 353 year: 2015 end-page: 358 ident: CR184 article-title: Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy publication-title: Surg Oncol Oxford doi: 10.1016/j.suronc.2015.09.002 – volume: 406 start-page: 463 year: 2021 end-page: 471 ident: CR108 article-title: Preoperative skeletal muscle index and visceral-to-subcutaneous fat area ratio are associated with long-term outcomes of elderly gastric cancer patients after gastrectomy publication-title: Langenbecks Arch Surg doi: 10.1007/s00423-021-02092-1 – volume: 31 start-page: 651 year: 2020 end-page: 662 ident: CR255 article-title: Central adiposity at diagnosis may reduce prostate cancer-specific mortality in African-Caribbean men with prostate cancer: 10-year follow-up of participants in a case–control study publication-title: Cancer Causes Control doi: 10.1007/s10552-020-01306-z – volume: 30 start-page: 164 year: 2012 end-page: 171 ident: CR240 article-title: Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations publication-title: J Clin Oncol doi: 10.1200/JCO.2011.36.2723 – volume: 29 start-page: 749 year: 2018 end-page: 757 ident: CR40 article-title: Body mass index and 20 specific cancers: re-analyses of dose-response meta-analyses of observational studies publication-title: Ann Oncol doi: 10.1093/annonc/mdx819 – volume: 136 start-page: 1940 year: 2015 end-page: 1947 ident: CR256 article-title: Prostate cancer incidence, clinical stage and survival in relation to obesity: a prospective cohort study in Denmark publication-title: Int J Cancer doi: 10.1002/ijc.29238 – volume: 22 start-page: S1041 issue: Suppl 3 year: 2015 end-page: S1047 ident: CR120 article-title: Prognostic impact of visceral fat amount and branched-chain amino acids (BCAA) in hepatocellular carcinoma publication-title: Ann Surg Oncol doi: 10.1245/s10434-015-4796-5 – volume: 17 start-page: 350 year: 2021 end-page: 363 ident: CR3 article-title: Metabolic pathways in obesity-related breast cancer publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-021-00487-0 – volume: 123 start-page: 627 year: 2010 end-page: 635 ident: CR30 article-title: Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-010-0990-0 – volume: 81 start-page: 127 year: 2021 end-page: 134 ident: CR223 article-title: CT-based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration-naive oligometastatic prostate cancer publication-title: Prostate doi: 10.1002/pros.24088 – volume: 11 start-page: 1655 year: 2019 ident: CR146 article-title: Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation publication-title: Cancers doi: 10.3390/cancers11111655 – volume: 8 start-page: 1672 year: 2019 ident: CR129 article-title: Impact of body composition on the risk of hepatocellular carcinoma recurrence after liver transplantation publication-title: J Clin Med doi: 10.3390/jcm8101672 – volume: 66 start-page: 225 year: 2014 end-page: 233 ident: CR260 article-title: Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP publication-title: Nutr Cancer Int J doi: 10.1080/01635581.2014.867065 – volume: 14 start-page: 355 year: 2016 end-page: 368 ident: CR28 article-title: Premorbid obesity and mortality in patients with pancreatic cancer: a systematic review and meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2015.09.036 – volume: 10 start-page: 111 year: 2019 end-page: 122 ident: CR80 article-title: The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12357 – volume: 146 start-page: 647 year: 2014 end-page: 655 ident: CR239 article-title: Central adiposity after breast cancer diagnosis is related to mortality in the Health, Eating, Activity, and Lifestyle study publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-3048-x – volume: 18 start-page: 28 year: 2019 end-page: 37 ident: CR124 article-title: Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients publication-title: Hepatobiliary Pancreat Dis Int doi: 10.1016/j.hbpd.2018.07.008 – volume: 7 start-page: 177 year: 1986 end-page: 188 ident: CR56 article-title: Meta-analysis in clinical trials publication-title: Control Clin Trials doi: 10.1016/0197-2456(86)90046-2 – volume: 7 start-page: 1630 year: 2018 end-page: 1641 ident: CR116 article-title: Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan publication-title: Cancer Med doi: 10.1002/cam4.1365 – volume: 59 start-page: 478 year: 2018 end-page: 484 ident: CR181 article-title: Body composition predictors of therapy response in patients with primary extremity soft tissue sarcomas publication-title: Acta Radiol doi: 10.1177/0284185117723370 – volume: 22 start-page: 455 year: 2015 end-page: 461 ident: CR172 article-title: Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy publication-title: Int J Urol doi: 10.1111/iju.12716 – volume: 158 start-page: 963 year: 2003 end-page: 968 ident: CR236 article-title: Waist-to-hip ratio and breast cancer mortality publication-title: Am J Epidemiol doi: 10.1093/aje/kwg236 – volume: 21 start-page: 3063 year: 2014 end-page: 3068 ident: CR121 article-title: Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-3686-6 – volume: 21 start-page: 2203 year: 2015 end-page: 2209 ident: CR259 article-title: Body Mass Index and waistline are predictors of survival for hepatocellular carcinoma after hepatectomy publication-title: Med Sci Monit doi: 10.12659/MSM.894202 – volume: 8 start-page: e1580128 year: 2019 ident: CR136 article-title: Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab publication-title: Oncoimmunology doi: 10.1080/2162402X.2019.1580128 – ident: CR168 – volume: 118 start-page: 607 year: 2018 end-page: 610 ident: CR254 article-title: Anthropometric measurements and survival after a prostate cancer diagnosis publication-title: Br J Cancer doi: 10.1038/bjc.2017.440 – volume: 29 start-page: 643 year: 2018 end-page: 656 ident: CR246 article-title: Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis publication-title: Cancer Causes Control doi: 10.1007/s10552-018-1042-z – volume: 8 start-page: 92 year: 2019 end-page: 109 ident: CR119 article-title: Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma publication-title: Liver Cancer doi: 10.1159/000488779 – volume: 25 start-page: e492 year: 2020 end-page: e501 ident: CR211 article-title: Computed tomography-based body composition is not consistently associated with outcome in older patients with colorectal cancer publication-title: Oncologist doi: 10.1634/theoncologist.2019-0590 – volume: 41 start-page: 828 year: 2021 end-page: 836 ident: CR230 article-title: High subcutaneous adipose tissue density correlates negatively with survival in patients with hepatocellular carcinoma publication-title: Liver Int doi: 10.1111/liv.14755 – volume: 133 start-page: 11 year: 2014 end-page: 15 ident: CR139 article-title: Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2014.01.031 – volume: 114 start-page: 44 year: 2021 end-page: 52 ident: CR186 article-title: Prediction of clinical outcomes through assessment of sarcopenia and adipopenia using computed tomography in adult patients with acute myeloid leukemia publication-title: Int J Hematol doi: 10.1007/s12185-021-03122-w – volume: 372 start-page: n71 year: 2021 ident: CR17 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ doi: 10.1136/bmj.n71 – volume: 35 start-page: 663 year: 2017 ident: CR212 article-title: Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer publication-title: Urol Oncol Semin Original Investig – volume: 163 start-page: 101 year: 2006 end-page: 107 ident: CR245 article-title: Association of overweight with breast cancer survival publication-title: Am J Epidemiol doi: 10.1093/aje/kwj017 – volume: 10 start-page: 187 year: 2019 ident: CR134 article-title: Low body mass index is an independent prognostic factor in patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitor publication-title: World J Oncol doi: 10.14740/wjon1244 – volume: 68 start-page: 201 year: 2016 end-page: 207 ident: CR152 article-title: Visceral obesity is associated with poor prognosis in pancreatic adenocarcinoma publication-title: Nutr Cancer Int J doi: 10.1080/01635581.2016.1134600 – volume: 62 start-page: 549 year: 2019 end-page: 560 ident: CR84 article-title: The impact of muscle and adipose tissue on long-term survival in patients with stage I to III colorectal cancer publication-title: Dis Colon Rectum doi: 10.1097/DCR.0000000000001352 – volume: 26 start-page: 12 year: 2017 ident: CR10 article-title: Next steps in understanding the obesity paradox in cancer publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-16-0764 – volume: 47 start-page: 560 year: 2021 end-page: 569 ident: CR179 article-title: Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer? publication-title: J Obstet Gynaecol Res doi: 10.1111/jog.14560 – start-page: 331 year: 2019 end-page: 42 ident: CR268 article-title: What Is the difference between a systematic review and a meta-analysis? publication-title: Basic methods handbook for clinical orthopaedic research: a practical guide and case based research approach doi: 10.1007/978-3-662-58254-1_37 – volume: 19 start-page: 1 year: 2019 end-page: 11 ident: CR196 article-title: No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer publication-title: BMC Cancer doi: 10.1186/s12885-019-6086-2 – volume: 172 start-page: 425 year: 2018 end-page: 436 ident: CR68 article-title: Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-018-4915-7 – volume: 24 start-page: 3732 year: 2017 end-page: 3740 ident: CR147 article-title: Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer publication-title: Ann Surg Oncol doi: 10.1245/s10434-017-6077-y – volume: 12 start-page: 3602 year: 2020 ident: CR218 article-title: Visceral adiposity as a significant predictor of sunitinib-induced dose-limiting toxicities and survival in patients with metastatic clear cell renal cell carcinoma publication-title: Cancers doi: 10.3390/cancers12123602 – volume: 200 start-page: 114 year: 2018 end-page: 120 ident: CR159 article-title: Subcutaneous fat distribution is a prognostic biomarker for men with castration resistant prostate cancer publication-title: J Urol doi: 10.1016/j.juro.2018.01.069 – volume: 36 start-page: 162 year: 2015 end-page: 172 ident: CR243 article-title: Impact of neighborhoods and body size on survival after breast cancer diagnosis publication-title: Health Place doi: 10.1016/j.healthplace.2015.10.003 – volume: 205 start-page: 800 year: 2021 end-page: 805 ident: CR231 article-title: Obesity is associated with longer survival independent of sarcopenia and myosteatosis in metastatic and/or castrate-resistant prostate cancer publication-title: J Urol doi: 10.1097/JU.0000000000001428 – volume: 26 start-page: 1803 year: 2015 end-page: 1811 ident: CR244 article-title: Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype publication-title: Cancer Causes Control doi: 10.1007/s10552-015-0673-6 – volume: 4 start-page: 798 year: 2018 end-page: 804 ident: CR62 article-title: Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2018.0137 – volume: 135 start-page: 1949 year: 2014 end-page: 1960 ident: CR249 article-title: Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations publication-title: Int J Cancer doi: 10.1002/ijc.28841 – volume: 42 start-page: 1180 year: 2018 end-page: 1191 ident: CR85 article-title: Impact of visceral adiposity as well as sarcopenic factors on outcomes in patients undergoing liver resection for colorectal liver metastases publication-title: World J Surg doi: 10.1007/s00268-017-4255-5 – volume: 11 start-page: 756 year: 2020 end-page: 767 ident: CR102 article-title: Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12540 – volume: 29 start-page: 1240 year: 2019 end-page: 1247 ident: CR96 article-title: Quantitative assessment of mesorectal fat: new prognostic biomarker in patients with mid-to-lower rectal cancer publication-title: Eur Radiol doi: 10.1007/s00330-018-5723-5 – volume: 11 start-page: 3310 year: 2020 end-page: 3317 ident: CR100 article-title: Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy publication-title: J Cancer doi: 10.7150/jca.37270 – volume: 375 start-page: 794 year: 2016 end-page: 798 ident: CR1 article-title: Body fatness and cancer-viewpoint of the IARC Working Group publication-title: N Engl J Med doi: 10.1056/NEJMsr1606602 – volume: 39 start-page: 45 year: 2017 end-page: 51 ident: CR215 article-title: Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: a retrospective cohort study publication-title: Int J Surg doi: 10.1016/j.ijsu.2017.01.075 – volume: 99 start-page: 550 year: 2012 end-page: 557 ident: CR95 article-title: Body composition and outcome in patients undergoing resection of colorectal liver metastases publication-title: Br J Surg doi: 10.1002/bjs.7823 – volume: 195 start-page: 74 year: 2015 end-page: 82 ident: CR22 article-title: Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer publication-title: J Surg Res doi: 10.1016/j.jss.2014.12.048 – volume: 343 start-page: d4002 year: 2011 ident: CR60 article-title: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials publication-title: BMJ doi: 10.1136/bmj.d4002 – volume: 47 start-page: 869 year: 2015 ident: 1613_CR126 publication-title: Dig Liver Dis doi: 10.1016/j.dld.2015.07.001 – volume: 179 start-page: 435 year: 2020 ident: 1613_CR207 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-019-05467-7 – volume: 172 start-page: 425 year: 2018 ident: 1613_CR68 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-018-4915-7 – volume: 139 start-page: 1065 year: 2016 ident: 1613_CR276 publication-title: Int J Cancer doi: 10.1002/ijc.30163 – volume: 22 start-page: 703 year: 2018 ident: 1613_CR203 publication-title: J Gastrointest Surg doi: 10.1007/s11605-017-3618-4 – volume: 25 start-page: 1489 year: 2014 ident: 1613_CR35 publication-title: Cancer Causes Control doi: 10.1007/s10552-014-0450-y – volume: 405 start-page: 469 year: 2020 ident: 1613_CR222 publication-title: Langenbecks Arch Surg doi: 10.1007/s00423-020-01901-3 – volume: 72 start-page: 7 year: 2022 ident: 1613_CR2 publication-title: CA Cancer J Clin doi: 10.3322/caac.21708 – volume: 50 start-page: 843 year: 2018 ident: 1613_CR206 publication-title: Cancer Res Treat doi: 10.4143/crt.2017.232 – volume: 17 start-page: 575 year: 2021 ident: 1613_CR91 publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2020.10.022 – volume: 40 start-page: 286 year: 2021 ident: 1613_CR71 publication-title: Clin Nutr doi: 10.1016/j.clnu.2020.05.019 – ident: 1613_CR16 – volume: 19 start-page: 1513 year: 2015 ident: 1613_CR219 publication-title: J Gastrointest Surg doi: 10.1007/s11605-015-2834-z – volume: 256 start-page: 425 year: 2021 ident: 1613_CR182 publication-title: Eur J Obstet Gynecol Reprod Biol doi: 10.1016/j.ejogrb.2020.11.050 – volume: 10 start-page: e0122047 year: 2015 ident: 1613_CR164 publication-title: PLoS ONE doi: 10.1371/journal.pone.0122047 – volume: 81 start-page: 127 year: 2021 ident: 1613_CR223 publication-title: Prostate doi: 10.1002/pros.24088 – volume: 27 start-page: 525 year: 2016 ident: 1613_CR273 publication-title: Epidemiology doi: 10.1097/EDE.0000000000000493 – ident: 1613_CR51 – volume: 21 start-page: 283 year: 2020 ident: 1613_CR266 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(19)30797-1 – volume: 27 start-page: 997 year: 2019 ident: 1613_CR69 publication-title: Obesity doi: 10.1002/oby.22458 – volume: 24 start-page: 353 year: 2015 ident: 1613_CR184 publication-title: Surg Oncol Oxford doi: 10.1016/j.suronc.2015.09.002 – volume: 375 start-page: 794 year: 2016 ident: 1613_CR1 publication-title: N Engl J Med doi: 10.1056/NEJMsr1606602 – volume: 19 start-page: 134 year: 2019 ident: 1613_CR75 publication-title: BMC Cancer doi: 10.1186/s12885-019-5319-8 – volume: 30 start-page: 100502 year: 2019 ident: 1613_CR183 publication-title: Gynecol Oncol Rep doi: 10.1016/j.gore.2019.100502 – volume: 12 start-page: 1063 year: 2011 ident: 1613_CR4 publication-title: Obes Rev doi: 10.1111/j.1467-789X.2011.00917.x – volume: 26 start-page: 12 year: 2017 ident: 1613_CR10 publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-16-0764 – volume: 37 start-page: 1279 year: 2018 ident: 1613_CR89 publication-title: Clin Nutr doi: 10.1016/j.clnu.2017.05.017 – volume: 119 start-page: 3377 year: 2013 ident: 1613_CR166 publication-title: Cancer doi: 10.1002/cncr.28218 – volume: 85 start-page: 111135 year: 2021 ident: 1613_CR110 publication-title: Nutrition doi: 10.1016/j.nut.2020.111135 – volume: 5 start-page: 1 year: 2016 ident: 1613_CR237 publication-title: Springerplus doi: 10.1186/s40064-015-1659-2 – volume: 179 start-page: 95 year: 2014 ident: 1613_CR242 publication-title: Am J Epidemiol doi: 10.1093/aje/kwt233 – volume: 14 start-page: 1832 year: 2010 ident: 1613_CR45 publication-title: J Gastrointest Surg doi: 10.1007/s11605-010-1297-5 – volume: 8 start-page: 105184 year: 2017 ident: 1613_CR187 publication-title: Oncotarget doi: 10.18632/oncotarget.21917 – volume: 181 start-page: 199 year: 2020 ident: 1613_CR64 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-020-05617-2 – volume: 10 start-page: 187 year: 2019 ident: 1613_CR134 publication-title: World J Oncol doi: 10.14740/wjon1244 – volume: 8 start-page: 1358 year: 2019 ident: 1613_CR210 publication-title: J Clin Med doi: 10.3390/jcm8091358 – volume: 163 start-page: 101 year: 2006 ident: 1613_CR245 publication-title: Am J Epidemiol doi: 10.1093/aje/kwj017 – volume: 59 start-page: 341 year: 2010 ident: 1613_CR82 publication-title: Gut doi: 10.1136/gut.2009.188946 – volume: 27 start-page: e12611 year: 2018 ident: 1613_CR267 publication-title: Eur J Cancer Care doi: 10.1111/ecc.12611 – volume: 287 start-page: 884 year: 2018 ident: 1613_CR175 publication-title: Radiology doi: 10.1148/radiol.2018171504 – volume: 8 start-page: 1672 year: 2019 ident: 1613_CR129 publication-title: J Clin Med doi: 10.3390/jcm8101672 – volume: 9 start-page: 326 year: 2018 ident: 1613_CR150 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12274 – volume: 22 start-page: 2416 year: 2015 ident: 1613_CR151 publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-4285-2 – volume-title: Meta-analysis with R year: 2015 ident: 1613_CR57 doi: 10.1007/978-3-319-21416-0 – volume: 14 start-page: e0218136 year: 2019 ident: 1613_CR127 publication-title: PLoS ONE doi: 10.1371/journal.pone.0218136 – volume: 403 start-page: 245 year: 2018 ident: 1613_CR106 publication-title: Langenbecks Arch Surg doi: 10.1007/s00423-018-1722-x – volume: 8 start-page: e1580128 year: 2019 ident: 1613_CR136 publication-title: Oncoimmunology doi: 10.1080/2162402X.2019.1580128 – volume: 12 start-page: E331 year: 2018 ident: 1613_CR160 publication-title: Can Urol Assoc J doi: 10.5489/cuaj.4923 – volume: 9 start-page: 629 year: 2008 ident: 1613_CR47 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(08)70153-0 – volume: 40 start-page: 1817 year: 2016 ident: 1613_CR18 publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2016.171 – volume: 327 start-page: 557 year: 2003 ident: 1613_CR58 publication-title: BMJ doi: 10.1136/bmj.327.7414.557 – volume: 50 start-page: 1088 year: 1994 ident: 1613_CR61 publication-title: Biometrics doi: 10.2307/2533446 – volume: 27 start-page: 205 year: 1977 ident: 1613_CR269 publication-title: CA Cancer J Clin doi: 10.3322/canjclin.27.4.205 – volume: 10 start-page: 1580 year: 2020 ident: 1613_CR178 publication-title: Quant Imaging Med Surg doi: 10.21037/qims.2020.02.09 – volume: 42 start-page: 1180 year: 2018 ident: 1613_CR85 publication-title: World J Surg doi: 10.1007/s00268-017-4255-5 – volume: 25 start-page: 3222 year: 2018 ident: 1613_CR107 publication-title: Ann Surg Oncol doi: 10.1245/s10434-018-6624-1 – volume: 68 start-page: 201 year: 2016 ident: 1613_CR152 publication-title: Nutr Cancer Int J doi: 10.1080/01635581.2016.1134600 – volume: 31 start-page: 1571 year: 2016 ident: 1613_CR76 publication-title: J Korean Med Sci doi: 10.3346/jkms.2016.31.10.1571 – volume: 36 start-page: 1509 year: 2012 ident: 1613_CR188 publication-title: World J Surg doi: 10.1007/s00268-012-1581-5 – volume: 8 start-page: 92 year: 2019 ident: 1613_CR119 publication-title: Liver Cancer doi: 10.1159/000488779 – volume: 159 start-page: 103232 year: 2021 ident: 1613_CR274 publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2021.103232 – volume: 112 start-page: 377 year: 2020 ident: 1613_CR201 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djz150 – volume: 73 start-page: 1056 year: 2018 ident: 1613_CR145 publication-title: Clin Radiol doi: 10.1016/j.crad.2018.07.094 – volume: 22 start-page: 1697 year: 2018 ident: 1613_CR180 publication-title: J Gastrointest Surg doi: 10.1007/s11605-018-3802-1 – volume: 19 start-page: 1 year: 2019 ident: 1613_CR196 publication-title: BMC Cancer doi: 10.1186/s12885-019-6086-2 – volume: 4 start-page: 798 year: 2018 ident: 1613_CR62 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2018.0137 – volume: 97 start-page: e13878 year: 2018 ident: 1613_CR98 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000013878 – volume: 13 start-page: e39 year: 2016 ident: 1613_CR156 publication-title: Clin Nutr ESPEN doi: 10.1016/j.clnesp.2016.04.001 – volume: 46 start-page: 243 year: 2015 ident: 1613_CR86 publication-title: J Gastrointest Cancer doi: 10.1007/s12029-015-9709-0 – volume: 103 start-page: 572 year: 2016 ident: 1613_CR88 publication-title: Br J Surg doi: 10.1002/bjs.10075 – volume: 8 start-page: 337 year: 2012 ident: 1613_CR232 publication-title: Asia Pac J Clin Oncol doi: 10.1111/j.1743-7563.2011.01512.x – volume: 39 start-page: 1895 year: 2015 ident: 1613_CR191 publication-title: World J Surg doi: 10.1007/s00268-015-3038-0 – volume: 105 start-page: 1862 year: 2013 ident: 1613_CR265 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djt310 – volume: 26 start-page: 1365 year: 2015 ident: 1613_CR23 publication-title: Cancer Causes Control doi: 10.1007/s10552-015-0635-z – volume: 124 start-page: 1996 year: 2011 ident: 1613_CR275 publication-title: Circulation doi: 10.1161/CIR.0b013e318233bc6a – volume: 18 start-page: 230 year: 2020 ident: 1613_CR87 publication-title: World J Surg Oncol doi: 10.1186/s12957-020-02006-3 – volume: 97 start-page: 2333 year: 1985 ident: 1613_CR15 publication-title: J Appl Physiol doi: 10.1152/japplphysiol.00744.2004 – volume: 43 start-page: 2052 year: 2018 ident: 1613_CR234 publication-title: Abdom Radiol doi: 10.1007/s00261-017-1418-7 – volume: 26 start-page: 1008 year: 2017 ident: 1613_CR72 publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-17-0200 – volume: 24 start-page: 1037 year: 2017 ident: 1613_CR189 publication-title: Ann Surg Oncol doi: 10.1245/s10434-016-5668-3 – volume: 26 start-page: 981 year: 2017 ident: 1613_CR11 publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-17-0144 – volume: 195 start-page: 74 year: 2015 ident: 1613_CR22 publication-title: J Surg Res doi: 10.1016/j.jss.2014.12.048 – volume: 19 start-page: 2229 year: 2010 ident: 1613_CR252 publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-10-0522 – volume: 10 start-page: 111 year: 2019 ident: 1613_CR80 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12357 – volume: 39 start-page: 45 year: 2017 ident: 1613_CR215 publication-title: Int J Surg doi: 10.1016/j.ijsu.2017.01.075 – volume: 135 start-page: 1949 year: 2014 ident: 1613_CR249 publication-title: Int J Cancer doi: 10.1002/ijc.28841 – volume: 102 start-page: 49 year: 2016 ident: 1613_CR25 publication-title: Lung Cancer doi: 10.1016/j.lungcan.2016.10.017 – volume: 15 start-page: 1918 year: 2008 ident: 1613_CR213 publication-title: Ann Surg Oncol doi: 10.1245/s10434-008-9891-4 – volume: 11 start-page: 139 year: 2020 ident: 1613_CR133 publication-title: World J Oncol doi: 10.14740/wjon1289 – volume: 64 start-page: 449S year: 1996 ident: 1613_CR41 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/64.3.449S – volume: 51 start-page: 604 year: 2015 ident: 1613_CR217 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2015.01.003 – volume: 10 start-page: 1079 year: 2021 ident: 1613_CR97 publication-title: J Clin Med doi: 10.3390/jcm10051079 – volume: 40 start-page: 3360 year: 2021 ident: 1613_CR99 publication-title: Clin Nutr doi: 10.1016/j.clnu.2020.11.007 – volume: 36 start-page: 162 year: 2015 ident: 1613_CR243 publication-title: Health Place doi: 10.1016/j.healthplace.2015.10.003 – ident: 1613_CR278 – volume: 24 start-page: 998 year: 2014 ident: 1613_CR49 publication-title: Eur Radiol doi: 10.1007/s00330-014-3110-4 – volume: 25 start-page: 1901 year: 2014 ident: 1613_CR20 publication-title: Ann Oncol doi: 10.1093/annonc/mdu042 – volume: 15 start-page: e0242785 year: 2020 ident: 1613_CR149 publication-title: PLoS ONE doi: 10.1371/journal.pone.0242785 – volume: 114 start-page: 44 year: 2021 ident: 1613_CR186 publication-title: Int J Hematol doi: 10.1007/s12185-021-03122-w – volume: 11 start-page: 11882 year: 2021 ident: 1613_CR208 publication-title: Sci Rep doi: 10.1038/s41598-021-91449-z – year: 2017 ident: 1613_CR247 publication-title: Sci Rep doi: 10.1038/s41598-017-07320-7 – volume: 29 start-page: 749 year: 2018 ident: 1613_CR40 publication-title: Ann Oncol doi: 10.1093/annonc/mdx819 – volume: 59 start-page: 478 year: 2018 ident: 1613_CR181 publication-title: Acta Radiol doi: 10.1177/0284185117723370 – volume: 12 start-page: 891 year: 2020 ident: 1613_CR167 publication-title: Cancer Manage Res doi: 10.2147/CMAR.S230973 – volume: 20 start-page: 314 year: 2017 ident: 1613_CR13 publication-title: Curr Opin Clin Nutr Metab Care doi: 10.1097/MCO.0000000000000395 – volume: 9 start-page: 53 year: 2018 ident: 1613_CR77 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12234 – volume: 81 start-page: 477 year: 2018 ident: 1613_CR197 publication-title: Acta Gastro-Enterol Belg – volume: 35 start-page: 215 year: 2010 ident: 1613_CR55 publication-title: J Educ Behav Stat doi: 10.3102/1076998609346961 – volume: 42 start-page: 2614 year: 2020 ident: 1613_CR117 publication-title: Head Neck doi: 10.1002/hed.26310 – volume: 16 start-page: 1565 year: 2011 ident: 1613_CR177 publication-title: Oncologist doi: 10.1634/theoncologist.2011-0213 – volume: 18 start-page: 56 year: 2016 ident: 1613_CR8 publication-title: Curr Oncol Rep doi: 10.1007/s11912-016-0539-4 – volume: 123 start-page: 627 year: 2010 ident: 1613_CR30 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-010-0990-0 – volume: 7 start-page: 177 year: 1986 ident: 1613_CR56 publication-title: Control Clin Trials doi: 10.1016/0197-2456(86)90046-2 – volume: 118 start-page: 607 year: 2018 ident: 1613_CR254 publication-title: Br J Cancer doi: 10.1038/bjc.2017.440 – volume: 36 start-page: 33 year: 2019 ident: 1613_CR204 publication-title: Dig Surg doi: 10.1159/000486143 – volume: 37 start-page: 101606 year: 2021 ident: 1613_CR224 publication-title: Surg Oncol doi: 10.1016/j.suronc.2021.101606 – volume: 63 start-page: 131 year: 2015 ident: 1613_CR118 publication-title: J Hepatol doi: 10.1016/j.jhep.2015.02.031 – volume: 9 start-page: 14058 year: 2018 ident: 1613_CR130 publication-title: Oncotarget doi: 10.18632/oncotarget.24500 – volume: 29 start-page: 643 year: 2018 ident: 1613_CR246 publication-title: Cancer Causes Control doi: 10.1007/s10552-018-1042-z – volume: 76 start-page: 228 year: 2021 ident: 1613_CR101 publication-title: Clin Imaging doi: 10.1016/j.clinimag.2021.03.035 – year: 2017 ident: 1613_CR173 publication-title: Med Oncol doi: 10.1007/s12032-017-0908-3 – volume: 109 start-page: 2894 year: 2013 ident: 1613_CR37 publication-title: Br J Cancer doi: 10.1038/bjc.2013.666 – volume: 96 start-page: 328 year: 2015 ident: 1613_CR26 publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2015.06.002 – volume: 12 start-page: 346 year: 2014 ident: 1613_CR104 publication-title: Int J Surg doi: 10.1016/j.ijsu.2014.01.010 – volume: 8 start-page: 833 year: 2017 ident: 1613_CR113 publication-title: J Gastrointest Oncol doi: 10.21037/jgo.2017.07.03 – volume: 2021 start-page: 6657566 year: 2021 ident: 1613_CR233 publication-title: Biomed Res Int doi: 10.1155/2021/6657566 – volume: 18 start-page: 28 year: 2019 ident: 1613_CR124 publication-title: Hepatobiliary Pancreat Dis Int doi: 10.1016/j.hbpd.2018.07.008 – volume: 109 start-page: 873 year: 2020 ident: 1613_CR131 publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2019.10.064 – volume: 51 start-page: 2570 year: 2015 ident: 1613_CR154 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2015.07.042 – volume: 76 start-page: 275 year: 1995 ident: 1613_CR248 publication-title: Iowa Women's Health Study Cancer – volume: 58 start-page: 839 year: 2009 ident: 1613_CR216 publication-title: Gut doi: 10.1136/gut.2008.164053 – volume: 91 start-page: E298 year: 2021 ident: 1613_CR73 publication-title: ANZ J Surg doi: 10.1111/ans.16708 – volume: 108 start-page: 169 year: 2013 ident: 1613_CR221 publication-title: J Surg Oncol doi: 10.1002/jso.23366 – volume: 66 start-page: 225 year: 2014 ident: 1613_CR260 publication-title: Nutr Cancer Int J doi: 10.1080/01635581.2014.867065 – volume: 16 start-page: 50 year: 2020 ident: 1613_CR262 publication-title: Tech Innov Patient Support Radiat Oncol doi: 10.1016/j.tipsro.2020.10.001 – volume: 13 start-page: 608 year: 2021 ident: 1613_CR66 publication-title: Cancers (Basel) doi: 10.3390/cancers13040608 – volume: 29 start-page: 1240 year: 2019 ident: 1613_CR96 publication-title: Eur Radiol doi: 10.1007/s00330-018-5723-5 – volume: 33 start-page: 997 year: 2008 ident: 1613_CR48 publication-title: Appl Physiol Nutr Metab doi: 10.1139/H08-075 – volume: 22 start-page: S1041 issue: Suppl 3 year: 2015 ident: 1613_CR120 publication-title: Ann Surg Oncol doi: 10.1245/s10434-015-4796-5 – volume: 47 start-page: 560 year: 2021 ident: 1613_CR179 publication-title: J Obstet Gynaecol Res doi: 10.1111/jog.14560 – volume: 8 start-page: e000821 year: 2020 ident: 1613_CR195 publication-title: J Immunotherapy Cancer doi: 10.1136/jitc-2020-000821 – volume: 17 start-page: 350 year: 2021 ident: 1613_CR3 publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-021-00487-0 – volume: 30 start-page: 1177 year: 2010 ident: 1613_CR257 publication-title: Turk Klin J Med Sci – volume: 4 start-page: 486 year: 2011 ident: 1613_CR19 publication-title: Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-10-0229 – volume: 50 start-page: 223 year: 2015 ident: 1613_CR155 publication-title: Endocrine doi: 10.1007/s12020-015-0525-x – volume: 17 start-page: 133 year: 2013 ident: 1613_CR92 publication-title: J Gastrointest Surg doi: 10.1007/s11605-012-2045-9 – volume: 12 start-page: 1605 year: 2020 ident: 1613_CR170 publication-title: Cancers doi: 10.3390/cancers12061605 – volume: 14 start-page: 355 year: 2016 ident: 1613_CR28 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2015.09.036 – volume: 19 start-page: 644 year: 2019 ident: 1613_CR74 publication-title: BMC Cancer doi: 10.1186/s12885-019-5837-4 – ident: 1613_CR54 – volume: 161 start-page: 382 year: 2021 ident: 1613_CR202 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2021.02.032 – volume: 33 start-page: 1019 year: 2018 ident: 1613_CR209 publication-title: Int J Colorectal Dis doi: 10.1007/s00384-018-3038-2 – volume: 26 start-page: 173 year: 2016 ident: 1613_CR165 publication-title: Horm Mol Biol Clin Investig doi: 10.1515/hmbci-2015-0075 – volume: 21 start-page: 2203 year: 2015 ident: 1613_CR259 publication-title: Med Sci Monit doi: 10.12659/MSM.894202 – volume: 23 start-page: 80 year: 2020 ident: 1613_CR65 publication-title: J Breast Cancer doi: 10.4048/jbc.2020.23.e8 – volume: 7 start-page: 261 year: 2018 ident: 1613_CR264 publication-title: Adipocyte doi: 10.1080/21623945.2018.1525252 – volume: 333 start-page: 1109 year: 2006 ident: 1613_CR6 publication-title: Obes Cancer BMJ – volume: 19 start-page: 6074 year: 2013 ident: 1613_CR5 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-2603 – volume: 205 start-page: 122 year: 2021 ident: 1613_CR158 publication-title: J Urol doi: 10.1097/JU.0000000000001321 – volume: 216 start-page: 1070 year: 2013 ident: 1613_CR79 publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2013.01.007 – volume: 25 start-page: e492 year: 2020 ident: 1613_CR211 publication-title: Oncologist doi: 10.1634/theoncologist.2019-0590 – volume: 5 start-page: 41 year: 2016 ident: 1613_CR67 publication-title: Cancer Med doi: 10.1002/cam4.571 – volume: 16 start-page: 71 year: 2011 ident: 1613_CR171 publication-title: Oncologist doi: 10.1634/theoncologist.2010-0227 – volume: 97 start-page: e10988 year: 2018 ident: 1613_CR199 publication-title: Medicine doi: 10.1097/MD.0000000000010988 – volume: 146 start-page: 647 year: 2014 ident: 1613_CR239 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-3048-x – volume: 55 start-page: 62 year: 2006 ident: 1613_CR250 publication-title: Gut doi: 10.1136/gut.2005.068189 – ident: 1613_CR59 – volume: 12 start-page: 1986 year: 2020 ident: 1613_CR70 publication-title: Cancers (Basel) doi: 10.3390/cancers12071986 – volume: 11 start-page: 9 year: 2020 ident: 1613_CR135 publication-title: World J Oncol doi: 10.14740/wjon1225 – volume: 129 start-page: 548 year: 2013 ident: 1613_CR140 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2013.03.003 – volume: 22 start-page: 1164 year: 1998 ident: 1613_CR9 publication-title: Int J Obes Relat Metab Disord doi: 10.1038/sj.ijo.0800741 – volume: 8 start-page: 255 year: 2019 ident: 1613_CR125 publication-title: Liver cancer doi: 10.1159/000493586 – volume: 11 start-page: 3310 year: 2020 ident: 1613_CR100 publication-title: J Cancer doi: 10.7150/jca.37270 – volume: 12 start-page: 3602 year: 2020 ident: 1613_CR218 publication-title: Cancers doi: 10.3390/cancers12123602 – volume: 9 start-page: 522 year: 2001 ident: 1613_CR258 publication-title: Support Care Cancer doi: 10.1007/s005200100268 – volume: 30 start-page: 164 year: 2012 ident: 1613_CR240 publication-title: J Clin Oncol doi: 10.1200/JCO.2011.36.2723 – volume: 4 start-page: e213520 year: 2021 ident: 1613_CR29 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.3520 – volume: 26 start-page: 1359 year: 2016 ident: 1613_CR226 publication-title: Eur Radiol doi: 10.1007/s00330-015-3963-1 – volume: 31 start-page: 651 year: 2020 ident: 1613_CR255 publication-title: Cancer Causes Control doi: 10.1007/s10552-020-01306-z – volume: 41 start-page: 1605 year: 2019 ident: 1613_CR115 publication-title: Head Neck doi: 10.1002/hed.25605 – volume: 11 start-page: 679158 year: 2021 ident: 1613_CR190 publication-title: Front Oncol doi: 10.3389/fonc.2021.679158 – volume: 133 start-page: 11 year: 2014 ident: 1613_CR139 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2014.01.031 – volume: 291 start-page: 547 year: 2019 ident: 1613_CR14 publication-title: Radiology doi: 10.1148/radiol.2019181796 – volume: 139 start-page: 1053 year: 2016 ident: 1613_CR241 publication-title: Int J Cancer doi: 10.1002/ijc.30158 – volume: 95 start-page: e3305 year: 2016 ident: 1613_CR33 publication-title: Medicine doi: 10.1097/MD.0000000000003305 – volume: 99 start-page: 550 year: 2012 ident: 1613_CR95 publication-title: Br J Surg doi: 10.1002/bjs.7823 – volume: 67 start-page: S60 issue: Suppl 1 year: 2013 ident: 1613_CR42 publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2012.166 – volume: 72 start-page: 436 year: 2018 ident: 1613_CR109 publication-title: Eur J Clin Nutr doi: 10.1038/s41430-017-0032-7 – ident: 1613_CR277 – volume: 5 start-page: 901 year: 2012 ident: 1613_CR31 publication-title: Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-12-0048 – volume: 62 start-page: 549 year: 2019 ident: 1613_CR84 publication-title: Dis Colon Rectum doi: 10.1097/DCR.0000000000001352 – volume: 11 start-page: 135 year: 2020 ident: 1613_CR112 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12484 – volume: 30 start-page: 114 year: 2021 ident: 1613_CR111 publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-20-0737 – volume: 24 start-page: 3732 year: 2017 ident: 1613_CR147 publication-title: Ann Surg Oncol doi: 10.1245/s10434-017-6077-y – volume: 22 start-page: 831 year: 2018 ident: 1613_CR225 publication-title: J Gastrointest Surg doi: 10.1007/s11605-018-3695-z – volume: 94 start-page: e1269 year: 2015 ident: 1613_CR32 publication-title: Medicine doi: 10.1097/MD.0000000000001269 – ident: 1613_CR43 – volume: 45 start-page: 210 year: 2015 ident: 1613_CR169 publication-title: Jpn J Clin Oncol doi: 10.1093/jjco/hyu193 – volume: 116 start-page: 98 year: 2019 ident: 1613_CR114 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2019.05.006 – volume: 18 start-page: 1 year: 2020 ident: 1613_CR138 publication-title: BMC Med doi: 10.1186/s12916-020-01733-4 – volume: 8 start-page: 317 year: 2017 ident: 1613_CR228 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12155 – volume: 6 start-page: 5280 year: 2014 ident: 1613_CR270 publication-title: Nutrients doi: 10.3390/nu6115280 – volume: 132 start-page: 625 year: 2013 ident: 1613_CR21 publication-title: Int J Cancer doi: 10.1002/ijc.27639 – volume: 15 start-page: 1871 year: 2006 ident: 1613_CR235 publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-06-0356 – volume: 22 start-page: 3946 year: 2015 ident: 1613_CR103 publication-title: Ann Surg Oncol doi: 10.1245/s10434-015-4432-4 – volume: 26 start-page: 861 year: 2018 ident: 1613_CR63 publication-title: Support Care Cancer doi: 10.1007/s00520-017-3902-6 – volume: 406 start-page: 463 year: 2021 ident: 1613_CR108 publication-title: Langenbecks Arch Surg doi: 10.1007/s00423-021-02092-1 – volume: 193 start-page: 1507 year: 2015 ident: 1613_CR192 publication-title: J Urol doi: 10.1016/j.juro.2014.11.088 – volume: 11 start-page: 8201 year: 2019 ident: 1613_CR137 publication-title: Cancer Manage Res doi: 10.2147/CMAR.S210958 – volume: 80 start-page: 1244 year: 2020 ident: 1613_CR157 publication-title: Prostate doi: 10.1002/pros.24054 – volume: 3 start-page: 329 year: 2019 ident: 1613_CR128 publication-title: JGH Open doi: 10.1002/jgh3.12167 – volume: 28 start-page: 285 year: 2018 ident: 1613_CR141 publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0000000000001165 – volume: 26 start-page: 17 year: 2017 ident: 1613_CR272 publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-16-0559 – volume: 15 start-page: e0238649 year: 2020 ident: 1613_CR144 publication-title: PLoS ONE doi: 10.1371/journal.pone.0238649 – volume: 141 start-page: 1237 year: 2015 ident: 1613_CR105 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-014-1893-y – volume: 19 start-page: 122 year: 2016 ident: 1613_CR39 publication-title: Prostate Cancer Prostatic Dis doi: 10.1038/pcan.2015.64 – volume: 59 start-page: 799 year: 2020 ident: 1613_CR93 publication-title: Acta Oncol doi: 10.1080/0284186X.2020.1744716 – volume: 23 start-page: 309 year: 2020 ident: 1613_CR163 publication-title: Prostate Cancer Prostatic Dis doi: 10.1038/s41391-019-0186-6 – volume: 39 start-page: 417 year: 2010 ident: 1613_CR271 publication-title: Int J Epidemiol doi: 10.1093/ije/dyp334 – volume: 205 start-page: 346 year: 2021 ident: 1613_CR27 publication-title: J Urol doi: 10.1097/JU.0000000000001377 – volume: 12 start-page: e0169136 year: 2017 ident: 1613_CR214 publication-title: PLoS ONE doi: 10.1371/journal.pone.0169136 – volume: 105 start-page: 365 year: 2012 ident: 1613_CR198 publication-title: J Surg Oncol doi: 10.1002/jso.22031 – volume: 62 start-page: 182 year: 2021 ident: 1613_CR81 publication-title: Acta Radiol doi: 10.1177/0284185120918373 – volume: 10 start-page: 2231 year: 2018 ident: 1613_CR123 publication-title: Cancer Manag Res doi: 10.2147/CMAR.S167417 – volume: 372 start-page: n71 year: 2021 ident: 1613_CR17 publication-title: BMJ doi: 10.1136/bmj.n71 – volume: 91 start-page: 635 year: 2010 ident: 1613_CR52 publication-title: Am J Clin Nutr doi: 10.3945/ajcn.2009.28385 – volume: 8 start-page: 175 year: 2019 ident: 1613_CR7 publication-title: Curr Nutr Rep doi: 10.1007/s13668-019-00280-6 – volume: 11 start-page: 756 year: 2020 ident: 1613_CR102 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12540 – volume: 16 start-page: 434 year: 2016 ident: 1613_CR194 publication-title: Clin Lymphoma Myeloma Leuk doi: 10.1016/j.clml.2016.04.010 – volume: 22 start-page: 62 year: 2020 ident: 1613_CR94 publication-title: Colorectal Dis doi: 10.1111/codi.14793 – volume: 31 start-page: 2472 year: 2021 ident: 1613_CR153 publication-title: Eur Radiol doi: 10.1007/s00330-020-07294-7 – volume: 123 start-page: 2188 year: 2008 ident: 1613_CR238 publication-title: Int J Cancer doi: 10.1002/ijc.23747 – volume: 11 start-page: 1655 year: 2019 ident: 1613_CR146 publication-title: Cancers doi: 10.3390/cancers11111655 – volume: 72 start-page: 4 year: 2018 ident: 1613_CR34 publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2017.70 – year: 2020 ident: 1613_CR161 publication-title: Front Oncol doi: 10.3389/fonc.2020.00558 – volume: 11 start-page: 10628 year: 2021 ident: 1613_CR44 publication-title: Sci Rep doi: 10.1038/s41598-021-90187-6 – volume: 7 start-page: 1630 year: 2018 ident: 1613_CR116 publication-title: Cancer Med doi: 10.1002/cam4.1365 – volume: 158 start-page: 963 year: 2003 ident: 1613_CR236 publication-title: Am J Epidemiol doi: 10.1093/aje/kwg236 – volume: 25 start-page: 1388 year: 2021 ident: 1613_CR220 publication-title: J Gastrointest Surg doi: 10.1007/s11605-020-04716-1 – volume: 41 start-page: 874 year: 2018 ident: 1613_CR24 publication-title: Am J Clin Oncol doi: 10.1097/COC.0000000000000388 – volume: 41 start-page: 828 year: 2021 ident: 1613_CR230 publication-title: Liver Int doi: 10.1111/liv.14755 – volume: 140 start-page: 292 year: 2017 ident: 1613_CR253 publication-title: Int J Cancer doi: 10.1002/ijc.30459 – volume: 12 start-page: 60 year: 2019 ident: 1613_CR78 publication-title: Cancers (Basel) doi: 10.3390/cancers12010060 – year: 2021 ident: 1613_CR46 publication-title: Front Mol Biosci doi: 10.3389/fmolb.2020.610229 – volume: 192 start-page: 1043 year: 2014 ident: 1613_CR176 publication-title: J Urol doi: 10.1016/j.juro.2014.03.107 – volume: 95 start-page: 409 year: 2016 ident: 1613_CR193 publication-title: Ann Hematol doi: 10.1007/s00277-015-2571-0 – start-page: 331 volume-title: Basic methods handbook for clinical orthopaedic research: a practical guide and case based research approach year: 2019 ident: 1613_CR268 doi: 10.1007/978-3-662-58254-1_37 – volume: 343 start-page: d4002 year: 2011 ident: 1613_CR60 publication-title: BMJ doi: 10.1136/bmj.d4002 – volume: 11 start-page: 534 year: 2020 ident: 1613_CR142 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12524 – volume: 13 start-page: 404 year: 2011 ident: 1613_CR261 publication-title: HPB (Oxford) doi: 10.1111/j.1477-2574.2011.00304.x – volume: 200 start-page: 114 year: 2018 ident: 1613_CR159 publication-title: J Urol doi: 10.1016/j.juro.2018.01.069 – volume: 26 start-page: 1803 year: 2015 ident: 1613_CR244 publication-title: Cancer Causes Control doi: 10.1007/s10552-015-0673-6 – volume: 205 start-page: 800 year: 2021 ident: 1613_CR231 publication-title: J Urol doi: 10.1097/JU.0000000000001428 – volume: 44 start-page: 1971 year: 2018 ident: 1613_CR38 publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2018.09.007 – volume: 136 start-page: 1940 year: 2015 ident: 1613_CR256 publication-title: Int J Cancer doi: 10.1002/ijc.29238 – volume: 78 start-page: 1906 year: 2018 ident: 1613_CR12 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-3287 – volume: 76 start-page: 41 year: 2020 ident: 1613_CR50 publication-title: Med J Armed Forces India doi: 10.1016/j.mjafi.2017.12.001 – volume: 85 start-page: 30 year: 2010 ident: 1613_CR174 publication-title: Urol Int doi: 10.1159/000318988 – volume: 10 start-page: e0118022 year: 2015 ident: 1613_CR205 publication-title: PLoS ONE doi: 10.1371/journal.pone.0118022 – volume: 25 start-page: 165 year: 1971 ident: 1613_CR53 publication-title: Br J Prev Soc Med – volume: 50 start-page: 308 year: 2018 ident: 1613_CR132 publication-title: Clin Imaging doi: 10.1016/j.clinimag.2018.05.006 – volume: 30 start-page: 3528 year: 2020 ident: 1613_CR200 publication-title: Eur Radiol doi: 10.1007/s00330-019-06630-w – volume: 52 start-page: 563 year: 2020 ident: 1613_CR83 publication-title: Cancer Res Treat doi: 10.4143/crt.2019.249 – volume: 35 start-page: 663 year: 2017 ident: 1613_CR212 publication-title: Urol Oncol Semin Original Investig – volume: 10 start-page: 854 year: 2021 ident: 1613_CR122 publication-title: Transl Cancer Res doi: 10.21037/tcr-20-2974 – volume: 10 start-page: 123 year: 2019 ident: 1613_CR229 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12358 – volume: 19 start-page: 2908 year: 2012 ident: 1613_CR143 publication-title: Ann Surg Oncol doi: 10.1245/s10434-012-2301-y – volume: 25 start-page: 370 year: 2020 ident: 1613_CR162 publication-title: Int J Clin Oncol doi: 10.1007/s10147-019-01559-y – volume: 22 start-page: 1782 year: 2020 ident: 1613_CR148 publication-title: HPB doi: 10.1016/j.hpb.2020.04.004 – volume: 22 start-page: 455 year: 2015 ident: 1613_CR172 publication-title: Int J Urol doi: 10.1111/iju.12716 – volume: 9 start-page: 13959 year: 2018 ident: 1613_CR36 publication-title: Oncotarget doi: 10.18632/oncotarget.24210 – ident: 1613_CR168 doi: 10.1016/j.urolonc.2017.12.011 – volume: 108 start-page: 104771 year: 2020 ident: 1613_CR185 publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2020.104771 – volume: 21 start-page: 3063 year: 2014 ident: 1613_CR121 publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-3686-6 – volume: 29 start-page: 956 year: 2020 ident: 1613_CR227 publication-title: Cancer Epidemiol Biomark Prev doi: 10.1158/1055-9965.EPI-19-1134 – volume: 142 start-page: 238 year: 2018 ident: 1613_CR251 publication-title: Int J Cancer doi: 10.1002/ijc.31049 – volume: 38 start-page: 491 year: 2018 ident: 1613_CR90 publication-title: Anticancer Res – volume: 7 start-page: 22 year: 2020 ident: 1613_CR263 publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2020.00022 |
SSID | ssj0005620 |
Score | 2.5519004 |
SecondaryResourceType | review_article |
Snippet | Purpose
The increasing availability of clinical imaging tests (especially CT and MRI) that directly quantify adipose tissue has led to a rapid increase in... The increasing availability of clinical imaging tests (especially CT and MRI) that directly quantify adipose tissue has led to a rapid increase in studies... PurposeThe increasing availability of clinical imaging tests (especially CT and MRI) that directly quantify adipose tissue has led to a rapid increase in... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1219 |
SubjectTerms | Adipose tissue Adiposity Biomedical and Life Sciences Biomedicine Body fat Breast cancer Cancer Research Carcinoma, Hepatocellular Colorectal cancer Colorectal carcinoma Colorectal Neoplasms Computed tomography Epidemiology Head and neck carcinoma Hematology Hepatocellular carcinoma Humans Kidney cancer Kidney Neoplasms Liver cancer Liver Neoplasms Lung cancer Lung carcinoma Male Meta-analysis Mortality Obesity Oncology Pancreatic cancer Pancreatic carcinoma Prostate cancer Public Health Review Article Survival Systematic review |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8QwEB48QAQRb6urRPBNA9s2V31bPBBBn1zwrWTTBBe0K3s8-O-dpO2u6wX2qZBpm8xMkpnOzBeAU2Njl3KWUiPbhjJWWKpNIqjGKzZZ28mArn__IG677O6JP9VFYaMm270JSYaV-lOxG-cJ9dnn3kxJqVyEZe59d9TibtKZJXaICowx4xLdLJbWpTI_v2N-O_pmY35PlfwSLw3b0M0GrNf2I-lUAt-EBVtuwcp9HSHfgrXqPxypyou24apT9ENi1jvRZUGMF_KQjCa4QqCOXRBNZljOpKpjCYSvdqyprhFLdqB7c_14eUvrkxOoYZKPaaGM8bA6sueUdiLWSjhfb9XDMTuGN1ohe7TiRsTOxigs5oH7CpcZw53I0l1YKgel3QeiC5EJpnEf68VMO6tEYQz6aaxtdapsEkHcMDA3Nay4P93iJZ8BInum58j0PDA9lxGcTZ95q0A1_qRuNXLJ6wk2yhOJpq7yQdEITqbNODV8vEOXdjAJNL5uGFeYCPYqMU4_l6Ij5U81j0DNCXhK4GG351vK_nOA3449LJ-U7QjOG12Y9ev3YRz8j_wQVhOvpyFvsAVL4-HEHqH9M-4dB3X_AD8O-ro priority: 102 providerName: Springer Nature |
Title | Adiposity and cancer survival: a systematic review and meta-analysis |
URI | https://link.springer.com/article/10.1007/s10552-022-01613-7 https://www.ncbi.nlm.nih.gov/pubmed/35971021 https://www.proquest.com/docview/2708085014 https://www.proquest.com/docview/2702975638 https://pubmed.ncbi.nlm.nih.gov/PMC10101770 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9MwED7BJiGkCcGAEdgmI_EGFk3i2A4vqB0tE2gVQlQqT5Hr2GISpNvaPuzf785xG3UTy0McyY4S353ts-_uO4B31qU-L0TOrepZLkTtuLGZ5Aav1JY9rwK6_tlYnk7Et2kxjQdui-hWuZ4Tw0Rdzy2dkX_MFOo2mqxgny8uOWWNIutqTKHxEHYJuoxcutRUdS4esoVlLAuFGy6Rx6CZGDpXFBknX3ZSenKuthemO9rmXafJW5bTsCCNnsKTqEmyfsv6Z_DANfvw6Czayvdhrz2RY22g0XP40q_Pg4vWNTNNzSyx-4otVjhXoLR9YoZ1qM6sjWgJDf-5peEmYpe8gMlo-OvklMccCtwKVSx5ra0lgB0189p4mRotPUVezbDPXuCD0UgeowsrU-9SZJsgCL_al9YWXpb5S9hp5o17BczUspTC4Io2S4XxTsvaWtyxiZ4zuXZZAumagJWNAOOU5-Jv1UEjE9ErJHoViF6pBN5v3rlo4TXubX245ksVh9qi6gQjgbebahwkZPkwjZuvQhuKIMa5JoGDlo2bz-W4paL85gnoLQZvGhAA93ZNc_4nAHGnBNCnVC-BD2tZ6P7r_914fX833sDjjOQyeAwews7yauWOUPNZzo6DeONdn6THsNsfDQZjKr_-_j7EcjAc__iJtZOsfwONwARI |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1faxQxEB_KFVQQ0fpvtWoEfdLg7W42yQki1bZcbe8QaaFv21w2wYLu1d4d0i_lZ3Qmm73lLPat-7Sws-xmMpnMZGZ-A_DKutTnhci5VX3LhagcNzaT3OCV2kHfq4CuPxrL4ZH4clwcr8GfthaG0ipbnRgUdTW1dEb-LlNo22iKgn08-8WpaxRFV9sWGo1Y7LuL3-iyzT7sbeP8vs6y3Z3Dz0MeuwpwK1Qx55W2liBn1MRr42VqtPRUizTBjc0LvDEazQ6jCytT71IciCBQu8oPrC28JPAlVPnrIkdXpgfrn3bGX791SSWyAYIcFApdPJHHMp1YrFcUGafseTKzcq5Wt8JL9u3lNM1_YrVhC9y9C3ei7cq2GmG7B2uu3oAboxid34DbzRkga0qb7sP2VnUaksIumKkrZknAztlsgdoJ5fs9M6zDkWZNDU0g_OnmhpuIlvIAjq6Fvw-hV09r9xiYqeRACoN76CQVxjstK2vRRxR9Z3LtsgTSloGljZDm1FnjR9mBMRPTS2R6GZheqgTeLN85awA9rqTebOeljIt7VnaimMDL5WNclhRrMbWbLgIN1SyjdkvgUTONy8_l6MRRR_UE9MoELwkI8nv1SX36PUB_pwQJqFQ_gbetLHT_9f9hPLl6GC_g5vBwdFAe7I33n8KtjGQ05CtuQm9-vnDP0O6aT55HYWdwct3r6y8Gljw5 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB9KhSKIaP2KVl1Bn3TpJdmvE0SK59FaW3ywcG9xb7OLBc3V3h3Sf82_zpnN5sJZ7FvzFMiGZGdnZmd2Zn4D8NL5PJRSlNzpgeNC1J5bVyhu8crdcBB0RNc_Olb7J-LTRE424E9XC0NplZ1OjIq6njk6I98tNNo2hqJguyGlRXwZjd-f_eLUQYoirV07jZZFDv3Fb3Tf5u8ORrjWr4pi_PHrh32eOgxwJ7Rc8No4R_AzehqMDSq3RgWqS5riJhcE3liDJog10qk8-BwnJQjgrg5D52RQBMSE6v-GLmVOMqYnuk8vUS0k5FBqdPZEmQp2UtmelAWnPHoyuEqu1zfFS5bu5YTNf6K2cTMc34HbyYpley3b3YUN32zD1lGK02_DrfY0kLVFTvdgtFefxvSwC2abmjlitXM2X6KeQk5_yyzrEaVZW00TB_70C8ttwk25DyfXQt0HsNnMGv8ImK3VUAmLu-k0FzZ4o2rn0FsUA29L44sM8o6AlUvg5tRj40fVwzIT0SskehWJXukMXq_eOWuhPa4cvdOtS5XEfF71TJnBi9VjFFCKutjGz5ZxDFUvo57L4GG7jKvPlejOUW_1DMzaAq8GEPj3-pPm9HsEAc8JHFDrQQZvOl7o_-v_03h89TSewxZKVfX54PjwCdwsiEVj4uIObC7Ol_4pGmCL6bPI6Qy-Xbdo_QV2Tj8J |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adiposity+and+Cancer+Survival%3A+A+Systematic+Review+and+Meta-analysis&rft.jtitle=Cancer+causes+%26+control&rft.au=Cheng%2C+En&rft.au=Kirley%2C+Jocelyn&rft.au=Cespedes%2C+Elizabeth+M.+Feliciano&rft.au=Caan%2C+Bette+J.&rft.date=2022-10-01&rft.issn=0957-5243&rft.eissn=1573-7225&rft.volume=33&rft.issue=10&rft.spage=1219&rft.epage=1246&rft_id=info:doi/10.1007%2Fs10552-022-01613-7&rft_id=info%3Apmid%2F35971021&rft.externalDocID=PMC10101770 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0957-5243&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0957-5243&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0957-5243&client=summon |